Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige    volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             5591 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 Chronic Anemia and Fatigue in Elderly Patients: Results of the First Randomized Double-Blind Placebo-Controlled Cross-Over Study with Epoetin Alfa. Agnihotri, P.

106 11 p. 3553
artikel
1002 Chronic Cutaneous GVHD Does Not Correlate with Frequency and FoxP3 Gene Expression of Regulatory T Cells. Haeusermann, Peter

106 11 p. 1819
artikel
1003 Chronic Graft-Versus-Host Disease after Allogenaic Bone Marrow Transplantation in Japan: Identification of Risk Factors and Prognostication. Atsuta, Yoshiko

106 11 p. 1808
artikel
1004 Chronic Graft Versus Host Disease (cGVHD) Following Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT): Higher Response Rate in Recipients of Unrelated Donor (URD) Umbilical Cord Blood (UCB). Arora, Mukta

106 11 p. 1814
artikel
1005 Chronic Hepatitis C Infection and Hematologic Malignancies: Is There an Association?. Boehringer, Peter A.

106 11 p. 2829
artikel
1006 Chronic Imatinib Mesylate Exposure Leads to Reduced Intracellular Drug Accumulation in K562 Cells Measured by High-Performance Liquid Chromatography. Jia, Yongqian

106 11 p. 4431
artikel
1007 Chronic Intermittent Administration of HIF Prolyl Hydroxylase Inhibitor Significantly Induces Erythropoietin and Increases Total Hemoglobin in Normal Rhesus Macaques. Hsieh, Matthew

106 11 p. 570
artikel
1008 Chronic Lymphocytic Leukaemia Patients with a Biallelic Deletion of 13q14 Have a More Favourable Profile of Prognostic Factors Compared with Cases That Have a Monoallelic 13q14 Deletion. Pettitt, Andrew R.

106 11 p. 5019
artikel
1009 Chronic Lymphocytic Leukemia Patients with a V1-69 Gene Rearrangement Do Not Have Inferior Survival with Respect to Patients That Express Other Unmutated VH Genes. Panovska, Irina

106 11 p. 1193
artikel
1010 Chronic Myeloid Leukemia (CML) Cells Express Tumor Associated Antigens Eliciting Specific CD8+ T Cell Responses Despite of Deficient Expression of Costimulatory Molecules. Greiner, Jochen

106 11 p. 2886
artikel
1011 Chronic Myeloid Leukemia during Pregnancy: Report of Management and Outcome in Seven Patients. Matias, Kleber

106 11 p. 4885
artikel
1012 Cidofovir: A Treatment for BK Virus Cystitis after Allogenic Bone Marrow Transplantation. Le Du, Katell

106 11 p. 5354
artikel
1013 Circulating B Lymphocytes from Patients with Multiple Myeloma Harbour T(4;14) Translocations and Chromosome 13 Deletions. Debes-Marun, Carina

106 11 p. 500
artikel
1014 Circulating CD56 Bright Natural Killer Cells after Allogeneic Stem Cell Trasnplantation Express Functional TRAIL; Implication for a Novel Target of Immunotherapy. Takao, Sumiko

106 11 p. 5403
artikel
1015 Circulating Cytokeratin 5+ Progenitor Epithelial Cells Also Express Other Progenitor Cell Markers and Are Necessary for Normal Airway Repair. Gomperts, Brigitte N.

106 11 p. 393
artikel
1016 Circulating Endothelial Cells Are an Indicator of Response to Treatment in Acute Myeloid Leukemia Patients. Wierzbowska, Agnieszka

106 11 p. 2776
artikel
1017 Circulating Endothelial Cells (CEC) and Angiogenesis-Related Factors in Multiple Myeloma (MM). Jobe, Dean A.

106 11 p. 5064
artikel
1018 Circulating Erythroid Progenitors and Predominant Contribution of Liver to Erythropoiesis in Adult Xenopus laevis. Nogawa, Nami

106 11 p. 4213
artikel
1019 Circulating Nucleic Acids in Multiple Myeloma: Presence of Non-Coding/ Intergenic DNA Reflects Disease Activity. Durie, Brian G.M.

106 11 p. 5095
artikel
1020 Circulating Platelet-Leukocyte Aggregates as a Marker of Microvascular Lesions in Diabetic Patients. Elalamy, Ismail

106 11 p. 3965
artikel
1021 Circulating Tie2-Expressing Cells Are Increased in Multiple Myeloma Patients, Correlate with Serum Pleiotrophin Levels and May Develop from This Myeloma Angiogenic and Growth Factor. Chen, Haiming

106 11 p. 2494
artikel
1022 Circulation Plays an Essential Role in Distributing Mammalian Yolk Sac Definitive Hematopoietic Progenitor Cells to the Embryo Proper; Using the Ncx1 Knockout Mouse Model To Prevent Circulation. Lux, Christopher

106 11 p. 517
artikel
1023 Cisplatin-Based Protocols as Salvage Therapy for Relapsed or Refractory Hodgkin's Lymphoma Patients. Alvarez, Iván

106 11 p. 2676
artikel
1024 Citation Impact of Breakthrough Interventions for Malignant Blood Disorders. Djulbegovic, Benjamin

106 11 p. 3115
artikel
1025 cJun Is Phosphorylated at Ser73 and Contributes to Cell Cycle Progression in Anaplastic Large Cell Lymphoma. Leventaki, Vassiliki

106 11 p. 2620
artikel
1026 Clarithromycin (Biaxin®), Low Dose Thalidomide and Dexamethasone (BLT-D) in Newly Diagnosed and Previously Treated African American Patients with Multiple Myeloma: A Retrospective, Single Institution Experience. Jacoub, Jack

106 11 p. 3501
artikel
1027 Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA). Tibes, Raoul

106 11 p. 484
artikel
1028 Clinical and Biological Features of 43 Acute Megakaryoblastic Leukemia (AMKL) in Children: A Comparison of Down Syndrome-AMKL and De Novo AMKL. Hama, Asahito

106 11 p. 2774
artikel
1029 Clinical and Economic Issues in Multiply Transfused Sickle Cell Disease (SCD) Patients. Sakhalkar, Vishwas S.

106 11 p. 1889
artikel
1030 Clinical and Endoscopic Presentation of Primary Gastric Lymphoma: An Italian Multicenter Study. Patti, Caterina

106 11 p. 4664
artikel
1031 Clinical and Genetic Profiles of the Aging Sickle Cell Patient. Ashley-Koch, Allison E.

106 11 p. 75
artikel
1032 Clinical and Interphase-FISH Studies of Deletion of Derivative Chromosome 9 in Patients with Chronic Myelogenous Leukemia. Wu, Wei

106 11 p. 4482
artikel
1033 Clinical and Laboratory Control of a Man with Chronic Recurrent Thrombotic Thrombocytopenic Purpura (TTP) Since Birth, with Bi-Weekly Infusion of Plasma. Shojania, A. Majid

106 11 p. 3978
artikel
1034 Clinical and Laboratory Features of Homozygous Sickle Cell Patients in Tanzania; Malaria, Infections and Cerebral Blood Flow Velocity. Makani, Julie

106 11 p. 3778
artikel
1035 Clinical and Laboratory Study of CAG Regimen in Treating AML Subtypes Hard To Cure. Xu, Jianmin

106 11 p. 4573
artikel
1036 Clinical and Laboratory Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 2003-01/608) in the Anti-Xa, Anti-LIA Heptest and Prothrombinase Induced Clotting (PiCT) Tests. Hoppensteadt, D.

106 11 p. 4147
artikel
1037 Clinical and Molecular Findings in Childhood Polycythemia Vera. Cario, Holger

106 11 p. 4961
artikel
1038 Clinical and Pharmacokinetic Results of a Four-Day Continuous Infusion of Full-Dose Busulfan in Patients (pts) Undergoing Matched Related (MRD) or Unrelated (MUD) Stem Cell Transplant (SCT). Shea, Thomas C.

106 11 p. 1752
artikel
1039 Clinical Application Study of Plasma Thrombmodulin. Lu, Xingguo

106 11 p. 4071
artikel
1040 Clinical Characteristics and Prognostic Factors of Mature T-Cell Lymphomas. A Single Center Experience on 39 Cases. Pappa, Vassiliki I.

106 11 p. 4652
artikel
1041 Clinical Characteristics and Prognostic Implications of NPM1 Mutations in Acute Myeloid Leukemia. Suzuki, Tatsuya

106 11 p. 2368
artikel
1042 Clinical Characteristics of Autosomal Dominat Giant Platelet Syndromes (GPS) and Mutation Analysis of MYH9 Encoding Non-Muscle Myosin Heavy Chain from 6 Unrelated Korean Patients. Kook, Hoon

106 11 p. 2169
artikel
1043 Clinical Classification of Myelofibrosis with Myeloid Metaplasia (MMM): Cluster Analysis of 861 Patients Enrolled into a Nationwide Prospective Registry (RIMM). Marchetti, M.

106 11 p. 2579
artikel
1044 Clinical Diagnosis and Management of Children with Large Splenic Hemangiomas Accompanied with Consumptional Coagulopathy. Ci, Pan

106 11 p. 4080
artikel
1045 Clinical Effects of Unrelated-Donor or Related-Donor Hematopoietic Stem Cell Transplantation for Leukemia. Liu, Qifa

106 11 p. 5436
artikel
1046 Clinical Efficacy and Safety of Wilate®, A New Generation, High-Purity VWF/FVIII-Concentrate with Optimized Pharmacokinetic Properties in the Treatment of Von Willebrand Disease. Windyga, Jerzy

106 11 p. 1795
artikel
1047 Clinical Evaluation of Bone Mineral Density (BMD) and Bone Metabolism in Hereditary Hemochromatosis (HH). Yau, Yu Ying

106 11 p. 3727
artikel
1048 Clinical Evaluation of CCL18/PARC and Chitotriosidase Biomarkers in Gaucher Disease. Alfonso, Pilar

106 11 p. 3885
artikel
1049 Clinical Features and Outcome of 147 Patients with Diffuse Large B-Cell Lymphoma and Hepatitis C Virus Infection. Visco, Carlo

106 11 p. 1921
artikel
1050 Clinical Features and Prognostic Factors in 135 NHL of the Head and Neck Treated by the GOELAMS 02 Trial. Laccourreye, Laurent

106 11 p. 942
artikel
1051 Clinical Impact of Increasing the Sensitivity of Activated Partial Thromboplastin Time (aPTT) Reagent for Lupus Anticoagulant. Razaq, Mohammad

106 11 p. 4106
artikel
1052 Clinical Impact of Respiratory Viruses in Haematopoietic Stemcell Transplantation; a Firm Association with Bronchiolitis Obliterans. Versluys, Birgitta

106 11 p. 3230
artikel
1053 Clinical Implication of Bone Marrow Angiogenesis in Childhood Acute Lymphocytic Leukemia. Won, Sung Chul

106 11 p. 1455
artikel
1054 Clinical Investigation of G-CSF-Priming Regimen in Treatment of Relapsing, Refractory and Senile Acute Myeloid Leukemia. Cai, Zhen

106 11 p. 4620
artikel
1055 Clinical Outcome of Hematopoietic Stem Cell Transplantation (HSCT) Using Plasma Depleted Umbilical Cord Blood Units (UCB) That Were Not Depleted of Red Blood Cells Prior to Cryopreservation. Chow, Robert

106 11 p. 2045
artikel
1056 Clinical Outcome of IgM Amyloidosis (AL) Following Stem Cell Transplantation. Gertz, Morie Abraham

106 11 p. 5470
artikel
1057 Clinical Outcome of Low Grade Non Hodgkin's Lymphoma Patients with Bone Marrow Involvement Detected by Flow Cytometry Alone. Lishner, Michael

106 11 p. 4672
artikel
1058 Clinical Outcome of Stem Cell Transplantation(SCT) in Patients with T Cell Prolymphocytic Leukaemia(T-PLL) Previously Treated with Alemtuzumab: A Multicentre Experience. Krishnan, Biju

106 11 p. 1127
artikel
1059 Clinical Outcome of the Treatment of Adult Acute Lymphoblastic Leukemia (ALL) with the Hyper-CVAD Protocol. Marinakis, Theodoros

106 11 p. 4588
artikel
1060 Clinical Outcomes and Prognostic Factors in Patients with Richter's Syndrome Treated with Chemotherapy and/or Immunotherapy with or without Stem Cell Transplantation. Tsimberidou, Apostolia-Maria

106 11 p. 2097
artikel
1061 Clinical Outcomes and the Impact of Anti-Thymocyte Globulin (ATG) and Chronic Graft Versus Host Disease (cGVHD) Following Pediatric Allogeneic Stem Cell Transplantation: A Comparison between Peripheral Blood and Bone Marrow as a Source of Stem Cells. Cheema, Parneet

106 11 p. 1809
artikel
1062 Clinical Outcomes in Adult T Leukemia/Lymphoma: Report of 55 Cases from Peru. Beltrán-Gárate, Brady E.

106 11 p. 4797
artikel
1063 Clinical Outcomes of Cord Blood Transplantation from Unrelated Donors Comparable with Marrow or Blood Transplantation from Related Donors in Adults: A Single Institute Analysis. Takahashi, Satoshi

106 11 p. 306
artikel
1064 Clinical Predictors of Abnormal Peripheral Blood Lymphocytoses Diagnosed by Flow Cytometry: An Algorithmic Approach That Can Be Applied in Routine Clinical Practice. Andrews, Jared M.

106 11 p. 3932
artikel
1065 Clinical Profile and Treatment Outcome in 92 Patients with AL Amyloidosis Associated with IgM Paraproteinaemia. Wechalekar, Ashutosh D.

106 11 p. 3498
artikel
1066 Clinical, Prognostic and Therapeutic Implications in the Diagnosis of Grade I Acute Graft-Versus-Host Disease. Saliba, Rima M.

106 11 p. 1799
artikel
1067 Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance. Fung, Sarah S.

106 11 p. 4983
artikel
1068 Clinical Relevance of CRp in Untreated AML. Estey, Elihu H.

106 11 p. 541
artikel
1069 Clinical Relevance of Cytogenetics Abnormalities in Adult Patients with Acquired Aplastic Anaemia. Gupta, Vikas

106 11 p. 3748
artikel
1070 Clinical Relevance of Spontaneous Apoptosis Is Independent from Multidrug Resistance in Acute Myeloid Leukemia (AML). Del Poeta, Giovanni

106 11 p. 333
artikel
1071 Clinical Report on 6 Children with Hematopoietic Disease with Umbilical Cord Blood Transplantation. Chen, Jing

106 11 p. 5447
artikel
1072 Clinical Research of Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors. Huang, Zhen-qian

106 11 p. 5475
artikel
1073 Clinical Response in ABLC-Treated Mould Infections, the CLEAR II™ Registry. Freifeld, Alison

106 11 p. 5556
artikel
1074 Clinical Response to Oral Low-Dose Cyclosporin in Myelodysplastic Syndrome: Study of 31 Cases from India. Kumar, Rajat

106 11 p. 4923
artikel
1075 Clinical Scale Expansion of Human Pluripotent Stem Cells. Perry, Robert

106 11 p. 1060
artikel
1076 Clinical Scale Preparation of B Lymphoblastoid Cell Line-Tumor Cell Hybridoma Cells for Vaccination in Patients with Relapsed Ewing's Sarcoma and Neuroblastoma. Lucas, Kenneth G.

106 11 p. 5218
artikel
1077 Clinical Significance of Minimal Residual Disease (MRD), as Assessed by Different Techniques, after Stem Cell Transplantation (SCT) for Chronic Lymphocytic Leukemia (CLL). Moreno, Carol

106 11 p. 2018
artikel
1078 Clinical Significance of Monoclonality by Flow Cytometry in Histologically Negative Bone Marrow in Patients with Diffuse B Cell Non Hodgkin's Lymphoma. Lahav, Meir

106 11 p. 4686
artikel
1079 Clinical Significance of Serum Th1-, Th2- and Regulatory T Cells-Associated Cytokines in Adult T-Cell Leukemia/Lymphoma: High Interleukin-5 and -10 Levels Are Significant Unfavorable Prognostic Factors. Inagaki, Atsushi

106 11 p. 2828
artikel
1080 Clinical Significance of the Philadelphia Chromosome Positive Pediatric Acute Lymphoblastic Leukemia in Chinese. Ye, Qidong

106 11 p. 4585
artikel
1081 Clinical Significance of the Tumor Suppressor p53 Codon 72 Polymorphic Variants in Multiple Myeloma. Gonzalez-Paz, Natalia C.

106 11 p. 5102
artikel
1082 Clinical Significance with Dynamic Changes of Telomarase Activity in Children with Acute Promyelocytic Leukemia (APL). Kong, XianMing

106 11 p. 4507
artikel
1083 Clinical Study of Fludarabine, Mitoxantrone, and Dexamethasone in the Treatment of Refractory or Relapsed Multiple Myeloma. Luo, Shao-Kai

106 11 p. 5187
artikel
1084 Clinical Study on Patients with Advanced Malignant Hematopoietic Disease by Non-T Cell Depleted Haploidentical Hematopoietic Stem Cells Transplantation. Yang, Mingzhen

106 11 p. 5451
artikel
1085 Clinical Tumor Responses Despite Graft Rejection after Nonmyeloablative Conditioning and Transplantation of Partially HLA-Mismatched (Haploidentical) Bone Marrow. Levy, Moshe Y.

106 11 p. 2897
artikel
1086 Clinicopathological and Prognostic Characteristics of CD33-Positive Multiple Myeloma. Sahara, Naohi

106 11 p. 3409
artikel
1087 CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL. Gorgun, Gullu

106 11 p. 50
artikel
1088 CLL/SLL Is More Common Than Registry Incidence Suggests: A Population-Based Study in Manitoba, Canada. Seftel, Matthew D.

106 11 p. 1334
artikel
1089 CLL Tumours with a Deletion of 11q Form Two Functional Subgroups Based on the Mutation Status of the Remaining ATM Allele. Austen, Belinda

106 11 p. 710
artikel
1090 Clofarabine and Clofarabine Plus Low-Dose Cytarabine (ara-C) as Induction Therapy for Patients (pts) ≥ 60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML). Faderl, Stefan

106 11 p. 2804
artikel
1091 Clofarabine Combinations in Acute Myeloid Leukemia (AML) Salvage: A Dose-Finding Phase I Study of Clofarabine Plus Idarubicin and Clofarabine/Idarubicin Plus Cytarabine (ara-C). Faderl, Stefan

106 11 p. 2803
artikel
1092 Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow. Inoue, Norimitsu

106 11 p. 3533
artikel
1093 Clonal Gammopathies Following Reduced Intensity Conditioning Transplantation with Fludarabine, Busulphan and Alemtuzumab for Myeloid Malignancies Predict Improved Overall Survival. Lim, ZiYi

106 11 p. 1410
artikel
1094 Clonal Genetic Progression in t(14;18)-Positive Follicular Lymphomas. d'Amore, Francesco

106 11 p. 995
artikel
1095 Clonal Involvement of the CD34+CD33− Progenitor Population by Leukemic Cells Harboring FLT3/ITD Correlates with High Risk of Relapse in Pediatric Acute Myeloid Leukemia. Wright, Jessica A.

106 11 p. 227
artikel
1096 Clonality Assay (X-CIP) and JAK 2 V617P Mutation: Clustering Patients with Essential Thrombocythemia at High Risk for Thrombosis. Fiorini, Alessia

106 11 p. 2597
artikel
1097 Clonal Marking of Mouse Hematopoietic Stem and Lymphoid Progenitor Cell Populations. Mojica-Henshaw, Mariluz P.

106 11 p. 5544
artikel
1098 Clonal Restriction in Endothelial Progenitor Cells in Patients with Multiple Myeloma. Braunstein, Marc

106 11 p. 2496
artikel
1099 Clonal T Cell Expansion in High Risk Myelodysplastic Syndrome (MDS). Painter, Jeffrey S.

106 11 p. 3435
artikel
1100 Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR. Miyoshi, Takuji

106 11 p. 1527
artikel
1101 Cloning of B Cell Lymphoma-Associated Antigens Using Modified Phage Displayed Expression cDNA Library and Immune Patient Sera. Cha, Soung-chul

106 11 p. 977
artikel
1102 Cloning of Idiotype Immunoglobulin Genes in B Cell Lymphomas by Anchored PCR and Production of Individual Recombinant Idiotype Vaccines in E. coli. Bertinetti, Cristina

106 11 p. 4821
artikel
1103 Clonotypic IgG B Cells in Waldenstrom Macroglobulinemia Cells Are Derived from Multiple Post-Transformed B Cells That Have Undergone Isotype Switch Recombination. Kriangkum, Jitra

106 11 p. 1002
artikel
1104 Clopidogrel Use in Children. Finkelstein, Yaron

106 11 p. 4156
artikel
1105 CLORETAZINE™ (VNP40101M) Is Active in Elderly Untreated Poor Risk Patients with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS). Giles, Francis

106 11 p. 2786
artikel
1106 c-Met Oncogene Enhances Fas-Mediated Apoptosis in B-ALL t(12;21) Cells. Accordi, Benedetta

106 11 p. 858
artikel
1107 C-met Receptor as a Potential Target for the Treatment of Patients with Multiple Myeloma. Majka, Marcin

106 11 p. 3395
artikel
1108 CML and Imatinib Mesylate: Response Related to Karyotype. Rubio-Martinez, Araceli

106 11 p. 4866
artikel
1109 CML Blasts Modify the Acetylation Pattern of Non Histone Proteins after Short Chain Fatty Acid Histone Deacetylase Inhibitor Treatment. Pastorelli, Roberta

106 11 p. 2884
artikel
1110 CML Progenitor Cells Have Chromsomal Instability and Display Increased DNA Damage at DNA Fragile Sites. Dierov, Jamil K.

106 11 p. 1989
artikel
1111 c-mpl Mutations in Congenital Amegakaryocytic Thrombocytopenia: Residual TPO Receptor Activity in Patients of Group CAMT II. Ballmaier, Matthias

106 11 p. 2157
artikel
1112 CMV Immunity Status in Older (>50 Years Old) Subjects after Non-Myeloablative or Reduced Intensity Regimen for Hematopoietic Cell Transplantation (HCT): A Comparison with a Younger Cohort after Ablative HCT. Gallez-Hawkins, Ghislaine

106 11 p. 3246
artikel
1113 CMV Infection and Disease after Nonmyeloablative (NM) HCT Revisited: Incidence, Risk Factors, Ganciclovir-Related Neutropenia and Outcome. Norasetthada, L.

106 11 p. 3247
artikel
1114 CMV Reactivation after Allogeneic Stem Cell Transplantation Is Associated with a Preponderance of Circulating Late-Stage CMV-Specific CD8+ T Cells. Komanduri, Krishna V.

106 11 p. 3250
artikel
1115 CMV-Seropositive Patients Allografted with a CMV-Seronegative Donor Show Delayed or Missing CMV-Specific T-Cell Immune Response and Are at Higher Risk for CMV-Viremia and CMV-Disease. Ganepola, Susanne

106 11 p. 3249
artikel
1116 c-Myb Is an Essential Downstream Target for Homeobox Mediated Transformation of Hematopoietic Cells. Slany, Robert K.

106 11 p. 666
artikel
1117 c-Myb Plays a Role InG2/M Cell Cycle Transition by Direct Regulation of Cyclin B1 Expression in Hematopoietic Cells. Nakata, Yuji

106 11 p. 1355
artikel
1118 C-myc Abnormalities in Non-Hodgkins Lymphoma - A Retrospective Review of Cytogenetic Patterns and Clinical Impact of c-myc Abnormalities by FISH Testing. Kukreti, Vishal

106 11 p. 1919
artikel
1119 C-MYC Induces KIR Expression Via a Novel Control Region Upstream of the Conventional Adult KIR Promoter. Haack, Becky

106 11 p. 764
artikel
1120 c-MYC Is a Major Downstream Target of NOTCH in T-Cell Acute Lymphoblastic Leukemia. Lau, Arthur

106 11 p. 3005
artikel
1121 CNS Involvement in Childhood and Adolescence Non-Hodgkin Lymphoma: Prevalence and Patient's Outcome Differ According to the Subtype. Salzburg, Janina

106 11 p. 233
artikel
1122 Coagulation and Fibrinolysis in Children with Acute Lymphoblastic Leukemia; Influences of Dexamethasone and L-Asparaginase. Appel, Inge M.

106 11 p. 2146
artikel
1123 Cobalamins and Cobinamides Inhibit Nitric Oxide Synthase Enzymatic Activity. Weinberg, J. Brice

106 11 p. 2225
artikel
1124 Cocktail Therapy Increased the Survival Rate of APL. Zhou, Jin

106 11 p. 899
artikel
1125 Coculture of Pediatric Acute Lymphoblastic Leukemia (ALL) Blasts with CD40 Ligand Transfected Cells Leads to Changes of Surface Antigens and RNA Expression. Stachel, Daniel K.

106 11 p. 856
artikel
1126 Cocultures of Umbilical Cord Blood Hematopoietic Progenitor Cells and Umbilical Cord Endothelium. Moldenhauer, Anja

106 11 p. 4204
artikel
1127 Coexistence of Mutated and Unmutated IgVH Forms in Patients with Chronic Lymphocytic Leukemia. Sheikholeslami, M.

106 11 p. 4984
artikel
1128 Co-Expression of BAALC with ERG, TCF4, and CD133 Indicates a Shared Pathway in Acute Myeloid and Lymphoblastic Leukemia. Baldus, Claudia D.

106 11 p. 2755
artikel
1129 Co-Inheritance of FV Leiden and High Levels of FIX Results in Novel Models for Thrombophilia and Spontaneous Fetal Loss. Freguia, Christian Furlan

106 11 p. 1946
artikel
1130 Co-Interaction and Increased Release of Tissue Factor Pathway Inhibitor by Heparanase. Nadir, Yona

106 11 p. 4038
artikel
1131 Collagen Type I (CTI) Stimulates Proplatelet Formation (PPF) of Murine Megakaryocytes and Platelet like Particle Formation (PP) of Human Megakaryoblastic Cell Line (MEG) through the Activation of Rac. Kowata, Shugo

106 11 p. 4280
artikel
1132 Collagen Type IV as Independent Prognostic Factor for Non-Hodgkin's Lymphoma. Hadzi-Pecova, Liljana

106 11 p. 4708
artikel
1133 Collection, In Vitro Expansion, and Freezing of Human Stem Cells of Fetal Origin. Machaj, Eugeniusz K.

106 11 p. 5268
artikel
1134 Colony Forming Unit-Endothelial Cells (CFU-EC) Are Derived from CD14+ Cells and Need Support by CD14− Cells. Van Beem, Rachel T.

106 11 p. 3685
artikel
1135 Combination Bortezomib (PS341, Velcade) and Rituximab Treatment Affects Multiple Survival and Death Pathways To Promote Apoptosis in Mantle Cell Lymphoma. Wadehra, Navin

106 11 p. 2407
artikel
1136 Combination Chemotherapy Using Cyclophosphamide and High Dose Dexamethasone with or without Radiotherapy for the Treatment of Multiple Myeloma. Kim, Chul Soo

106 11 p. 5168
artikel
1137 Combination Chemotherapy with Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Induces a High Response Rate in Previously Untreated CLL. Bosch, Francesc

106 11 p. 718
artikel
1138 Combination of Akt/PKB Inhibition (Perifosine) and Farnesyl Transferase Inhibition (Tipifarnib) Results in Increased Cell Death in Myeloma Cells Lines. Sinha, Rajni

106 11 p. 1568
artikel
1139 Combination of Daunorubicin and Cytarabine Chemotherapy with Gemtuzumab Ozogamicin as Initial Therapy for Elderly Patients with Previously Untreated Acute Myeloid Leukemia. Kujawski, Lisa A.

106 11 p. 4636
artikel
1140 Combination of Farnesyl Transferase Inhibitor (Tipifarnib) with Perifosine Induces Apoptosis through phos-PDK1 in Human Lymphoma and Leukemia Cell Lines. David, Ebenezer

106 11 p. 1488
artikel
1141 Combination of Fludarabine (FAMP) Cyclophosphamide (CTX) and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL). Tedeschi, Alessandra

106 11 p. 5036
artikel
1142 Combination of Motexafin Gadolinium (MGd) with 90Y Ibritumomab Tiuxetan (Zevalin®; 90Yttrium-Zevalin) Radioimmunotherapy (RIT) Produces High Complete Remission Rates in Relapsed Rituximab-Refractory Follicular Non- Hodgkin's Lymphoma (NHL). Evens, Andrew M.

106 11 p. 2450
artikel
1143 Combination of PP1/PP2 and LY294002 Induce Apoptosis Efficiently to TEL-FGFR3 Transfected Ba/F3 Cells. Okamura, Daisuke

106 11 p. 4465
artikel
1144 Combination of Proteasome Inhibitor PS 341 (Velcade®) with Histone Acetylase Inhibitor (HDAC) PXD 101 Shows Superior Anti-Myeloma Activity and Inhibits Osteoclastogenesis. Lentzsch, Suzanne

106 11 p. 2488
artikel
1145 Combination of the AKT Inhibitor Perifosine with the HSP90 Inhibitor 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin (17-DMAG) Has Synergistic Activity in Multiple Myeloma (MM). Huston, Alissa

106 11 p. 1592
artikel
1146 Combination of the mTOR Inhibitor Rapamycin with the HSP90 Inhibitor 17-AAG Has Synergistic Activity in EBV Positive Post Transplant Lymphoproliferative Disorders (PTLD). Alsayed, Yazan

106 11 p. 2414
artikel
1147 Combinations of the FLT3 Inhibitor CEP-701 and Chemotherapy Synergistically Kill Infant and Childhood MLL-Rearranged ALL Cells in a Sequence-Dependent Manner. Brown, Patrick

106 11 p. 2467
artikel
1148 Combinations of ZAP-70, CD38 and IgVH Mutational Status as Predictors of Time to First Treatment in CLL. Morilla, Alison

106 11 p. 711
artikel
1149 Combination Therapy of Bortezomib with Low-Dose Bendamustine in Elderly Patients with Advanced Multiple Myeloma. Hrusovsky, Irena

106 11 p. 5122
artikel
1150 Combination Therapy with Lenalidomide Plus Dexamethasone (Rev/Dex) for Newly Diagnosed Myeloma. Rajkumar, S. Vincent

106 11 p. 781
artikel
1151 Combination Therapy with Velcade, Doxil, and Dexamethasone (VDD) for Patients with Relapsed/Refractory Multiple Myeloma (MM). Jakubowiak, Andrzej J.

106 11 p. 5179
artikel
1152 Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic Myeloid Leukemia. Fruehauf, Stefan

106 11 p. 1105
artikel
1153 Combined Chemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience. Pavlovsky, Santiago

106 11 p. 5033
artikel
1154 Combined Cytoreduction and Infusion of Anti-CD3/Anti-CD28 Bead-Activated T Cells Prevent Diabetes in NOD Mice. Berenson, Ronald J.

106 11 p. 3036
artikel
1155 Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin's Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG). Engert, Andreas

106 11 p. 2673
artikel
1156 Combined Muliparameter Approach to the Diagnosis of Polycythemia Vera and Essential Thrombocythemia. Teofili, Luciana

106 11 p. 4950
artikel
1157 Combined Overexpression of Bcl-2 and SOCS3 Is Associated with Decreased Survival in a Cohort of Patients with De Novo Follicular Lymphoma. Krishnadasan, Ravitharan

106 11 p. 989
artikel
1158 Combined Schedule of Fludarabine and Alemtuzumab Followed by Maintenance with Low-Dose Alemtuzumab Is Effective for Patients with Progressive B-Cell Chronic Lymphocytic Leukemia. Kowal, Malgorzata

106 11 p. 5048
artikel
1159 Combined Therapy with Alemtuzumab and Pentostatin Is Feasible and Effective in T- Lymphoprolifertive Disorders. Ravandi-Kashani, Farhad

106 11 p. 5024
artikel
1160 Combined Use of Warfarin and Aspirin Decreases Mortality in Patients with Peripheral Arterial Disease. Pasquale, Donald

106 11 p. 4155
artikel
1161 Combining Immunocytokine with Adoptive Immunotherapy To Treat B-Lineage Lymphomas. Singh, Harjeet

106 11 p. 343
artikel
1162 Combining Measurements of Plasma Cell Apoptosis and Proliferation in Multiple Myeloma Identifies Patients with Poor Survival. Kumar, Shaji

106 11 p. 3410
artikel
1163 Common Variable Immunodeficiency Presenting with Hodgkin's Disease. Ellwood, Amanda

106 11 p. 4642
artikel
1164 Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response. Lange, Thoralf

106 11 p. 1985
artikel
1165 Comparaison of Serum Free Light Chain Measurement with Classical Methods for the Evaluation of Patients with Immunoproliferative Diseases under Treatment. Cattan, Florence

106 11 p. 5123
artikel
1166 Comparative Analysis of Ablative and Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation in Treatment of Adult Patients with Chronic Myeloid Leukemia. Gil, Lidia

106 11 p. 5414
artikel
1167 Comparative Effect of the Oral Iron Chelators ICL670A and CP20 on Cell Proliferation, Apoptosis and Polyamine Metabolism in Rat and Human Liver Cell Cultures. Gaboriau, François

106 11 p. 4448
artikel
1168 Comparative Effects of Transfusion Program, Hydroxyurea or Stem Cell Transplant on Frequency of Hospitalisations in Pediatric Sickle Cell Patients. Arnaud, Cecile

106 11 p. 318
artikel
1169 Comparative Evaluation of Hematologic Analyzers Advia® 120, Advia® 2120 and Pentra® 120DX for Platelet Counts below 40 X 109/L. Jou, Josep M.

106 11 p. 1256
artikel
1170 Comparative Genomic Analysis of the 5′-Upstream Sequences of von Willebrand Factor and 27 Other Endothelial-Specific Genes Identifies Conserved Noncoding Sequences That Are DNase Hypersensitive. Bernat, John A.

106 11 p. 2650
artikel
1171 Comparative Outcome of Reduced Intensity and Myeloablative Preparative Regimen in HLA Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years of Age with Acute Myeloblastic Leukaemia: A Retrospective Survey from the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT). Aoudjhane, Malek

106 11 p. 1139
artikel
1172 Comparative Pharmacodynamics of TGN 255, a Novel Direct Thrombin Inhibitor and Unfractionated Heparin in Healthy Volunteers. Combe, Sophie

106 11 p. 1864
artikel
1173 Comparative Study of Chimerism Dynamics between Allogenic Bone Marrow Transplantation and Nonmyeloablative Stem Cell Transplantation. Tang, Xiaowen

106 11 p. 5402
artikel
1174 Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins as Measured by Whole Blood Act, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay. Hoppensteadt, D.

106 11 p. 4148
artikel
1175 Comparing Platelet Loss in 2 Common Apheresis Machines for Collecting Autologous Peripheral Blood Stem Cells (PBSC). Law, Ping

106 11 p. 5261
artikel
1176 Comparison among Related Peripheral Blood Stem Cell Transplantation (R-PBSCT), Unrelated Bone Marrow Transplantation (U-BMT), and Unrelated Cord Blood Transplantation (U-CBT) with Reduced Intensity Regimens for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Miyakoshi, Shigesaburo

106 11 p. 5441
artikel
1177 Comparison between 2-Deoxy-2-[18f]Fluoro-D-Glucose Positron Emission (FDG-PET) and Computed Tomography (CT) for Staging of Patients with Hodgkin's Lymphoma (HL). Rigacci, Luigi

106 11 p. 975
artikel
1178 Comparison of Activated Partial Thromboplastin Time Ratios with Ecarin Clotting Time Ratios for Monitoring Direct Thrombin Inhibitor Therapy: In-Vitro Study and Case Study of Lepirudin Therapy. Messmore, Harry L.

106 11 p. 4149
artikel
1179 Comparison of Anti-Angiogenic Activities of Thalidomide and Lenalidomide In Vitro. Zhang, Ling-Hua

106 11 p. 3959
artikel
1180 Comparison of aPTT (Platelin LS®) and Dilute Russell's Viper Venom (Viperquik LA Test®) for the Screening of Lupus Anticoagulant in Patients with Venous Thromboembolism. Roprigues, Celso A.

106 11 p. 4122
artikel
1181 Comparison of Biodistributions and Therapeutic Efficacies of Pretargeted Radioimmunoconjugates Targeting the CD20, CD22, and DR Molecules on Human B Cell Lymphomas. Pantelias, Anastasia

106 11 p. 611
artikel
1182 Comparison of Bone Marrow Biopsy, Flow Cytometry and PCR Assays To Detect Bone Marrow Involvement in B-Cell Non-Hodgkin Lymphomas. Carulli, Giovanni

106 11 p. 4670
artikel
1183 Comparison of Cationic Propyl Gallate and Adenosine Diphosphate for the Meassurement of Aspirin Effectivity with Optical Aggregometry. Motovska, Zuzana

106 11 p. 3943
artikel
1184 Comparison of Closure Times and Bleeding Times in the Evaluation of Patients Referred for Mild Bleeding Disorder Evaluations. Zeigler, Zella Rose

106 11 p. 1789
artikel
1185 Comparison of CXCR-4 and Adhesion Molecule Expression in Healthy Bone Marrow with Expression in Bone Marrow and Peripheral Blood of Patients Receiving G-CSF Plus AMD3100. Oelschlaegel, Uta

106 11 p. 1974
artikel
1186 Comparison of Cytogenetics and Interphase Fluorescence In Situ Hybridization in Newly Diagnosed Ph+ Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate. A Study by the GIMEMA Working Party on CML. On Behalf of GWP on CML. Testoni, Nicoletta

106 11 p. 4857
artikel
1187 Comparison of Different TBI Based Conditioning Regimen in Pediatric Haematological Malignancies: A Retrospective Study of 702 Patients from French Registry. Maurin, C.

106 11 p. 840
artikel
1188 Comparison of Enoxaparin to the Thrombin Variant Protein C Activator, W215A/E217A, in a Primate Model of Thrombosis. Marzec, Ulla M.

106 11 p. 1868
artikel
1189 Comparison of Factor XIII Concentration in Cryoprecipitated Plasma Versus Fresh Frozen Plasma. Caudill, J.S.

106 11 p. 4169
artikel
1190 Comparison of Genomic Aberrations and Expression of ZAP-70 and CD38. Yañez, Lucrecia

106 11 p. 5004
artikel
1191 Comparison of Hematopoietic Reconstitution after Autologous Transplantation Using Stem Cells after Short- (<12 Months) and Longer-Term Cryostorage. Lowenthal, Raymond M.

106 11 p. 5498
artikel
1192 Comparison of HLA-Identical Sibling Hematopoietic Stem Cell Transplant (HCT) Versus Chemotherapy as Postremission Therapy in t(8;21) Acute Myeloid Leukemia (AML). Pasquini, Marcelo C.

106 11 p. 1138
artikel
1193 Comparison of Human IL-11 and PTH: Effect on Blood and Bone Parameters in Adult Ovariectomized Mice. Liu, Ling

106 11 p. 4282
artikel
1194 Comparison of Human Stem Cell Homing after Intravenous or Intra-Femoral Transplantation Using Multimodal In Vivo Imaging of Repopulating Human CD34+ Cells Labeled with Far-Red Fluorescent-Conjugated Nanoparticles. Bonde, Jesper

106 11 p. 2196
artikel
1195 Comparison of IgH Gene Rearrangement Configuration between Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-v). Gonzalez, David

106 11 p. 4997
artikel
1196 Comparison of Imatinib, AMN107 and Dasatinib in an Accelerated Cell-Based Mutagenesis Screen. Deininger, Michael W.N.

106 11 p. 691
artikel
1197 Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Children with Very High-Risk Acute Lymphoblastic Leukemia (VHR-ALL). Final Results of the PETHEMA ALL-93 Trial. Ribera, Josep-Maria

106 11 p. 173
artikel
1198 Comparison of Interferon Versus Thalidomide Versus RIC Allotransplant for Maintenance /Consolidation Therapy after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Single Center Experience. Fenk, Roland

106 11 p. 1168
artikel
1199 Comparison of Iron Load of the Liver and Gum of Patients with Thalassemia Major. Caliskan, Umran

106 11 p. 3813
artikel
1200 Comparison of LIC Obtained from Biopsy, BLS and R2-MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670). Piga, A.

106 11 p. 2689
artikel
1201 Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease. Fung, Ellen B.

106 11 p. 3721
artikel
1202 Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation. Saito, Akiko M.

106 11 p. 1797
artikel
1203 Comparison of Myeloma Cell Gene Expression Profiles Pre and Post Thalidomide - Dexamethasone Therapy Provides Insight into Potential Mechanisms. Kumar, Shaji

106 11 p. 3480
artikel
1204 Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells. Kumar, Shaji

106 11 p. 1555
artikel
1205 Comparison of Oral and Intravenous Fludarabine in the LRF CLL4 Trial. Hillmen, Peter

106 11 p. 722
artikel
1206 Comparison of Outcome of Unselected Patients with Diffuse Large B-Cell Lymphoma Diagnosed before and after Approval of Rituximab in France in This Indication. Ghesquières, Hervé

106 11 p. 4766
artikel
1207 Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival. Wildes, Tanya M.

106 11 p. 2086
artikel
1208 Comparison of Out-of-Pocket Costs for Patients (pts) with Hodgkin's Disease (HD), Indolent Non-Hodgkin's Lymphoma (INHL) and Aggressive Non-Hodgkin's Lymphoma (ANHL). McCaffrey, Kathryn

106 11 p. 2241
artikel
1209 Comparison of Pathology Transform of Liver, Spleen, Intestinal Tract and Skin with Acute Graft-Versus-Host Disease in Mice. Wang, Chunyan

106 11 p. 5238
artikel
1210 Comparison of Patient Satisfaction between Medical Staff and Clinical Nurse Specialist Performing Bone Marrow Investigation Procedure. Pattison, John W.

106 11 p. 5574
artikel
1211 Comparison of Performance of Two Clinical Scales To Diagnose the Post-Thrombotic Syndrome: Correlation with Patient-Reported Disease Burden and Valvular Reflux. Kahn, Susan R.

106 11 p. 4114
artikel
1212 Comparison of Rapid Platelet Function Assay with Whole Blood Platelet Impedance Aggregometry for the Definition of Aspirin Resistance. Dyszkiewicz-Korpanty, Anna M.

106 11 p. 4018
artikel
1213 Comparison of Small Lymphocytic Lymphoma with Chronic Lymphocytic Leukemia The M.D Anderson Cancer Center Experience. Tsimberidou, Apostolia-Maria

106 11 p. 921
artikel
1214 Comparison of Stem Cells Harvested from Adipose Tissue and Bone Marrow. Ogawa, Rei

106 11 p. 4221
artikel
1215 Comparison of the Efficacy and Toxicity of Fludarabine (F) in First Line Therapy of Younger Versus Elderly Patients (Pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Meta-Analysis of Two Phase III Trials of the German CLL Study Group (GCLLSG). Eichhorst, Barbara F.

106 11 p. 717
artikel
1216 Comparison of the Peripheral Blood Stem Cell Mobilization and Harvest after Each Consolidation Chemotherapy in Patients with Acute Myeloid Leukemia in First Complete Remission Who Underwent Autologous Stem Cell Transplantation. Shin, Ho-Jin

106 11 p. 5495
artikel
1217 Comparison of the Proliferative Kinetics, GVHD Potential and GCV Sensitivity of Naive and Transduced and Selected Murine T Cells after Allogeneic BMT. Rettig, Michael

106 11 p. 5257
artikel
1218 Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin's Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial. Eghbali, Houchingue

106 11 p. 814
artikel
1219 Comparison of Two Induction Regimens, High Dose Cytarabine /Mitoxantrone vs Hyper-CVAD, for Adult Acute Lymphoblastic Leukemia/Lymphoma. Jeong, Woondong

106 11 p. 4589
artikel
1220 Comparison of Umbilical Cord Blood Derived Mononuclear Cells and Endothelial Generating Cells in Response to Ischemia in the Murine Hind-Limb Injury Model. Finney, Marcie R.

106 11 p. 3973
artikel
1221 Comparison of Umbilical Cord Collection Methods: Impact on Cellularity and Microbial Contamination Rates. Foster, Karen A.

106 11 p. 5279
artikel
1222 Comparison of Uptake and Intracellular Induced Structural Changes of Arsenic Trioxide, an Inorganic Compound, and Organic Arsenic Derivative S-Dimethylarsino-Glutathione (SGLU; ZIO-101) in NB4 Acute Promyelocytic Leukemia (APL) Cells. Manshouri, Taghi

106 11 p. 4446
artikel
1223 Comparison of Viral Vectors for Gene Transfer into CLL Cells: Efficient Transduction with Adeno-Associated Virus-8 (AAV-8). Jewell, Andrew P.

106 11 p. 2985
artikel
1224 Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM). Chng, Wee-Joo

106 11 p. 1539
artikel
1225 Competitive Repopulation Assay for Human Stem Cell Engraftment in NOD-scid IL-2rγ nul Mice. Giassi, Lisa J.

106 11 p. 5215
artikel
1226 Complementary Diagnostic and Prognostic Value of Parallel Karyotyping and Molecular Diagnostics in Patients with Acute Leukemias. Ejduk, Anna

106 11 p. 4527
artikel
1227 Complement-Induced Cell Death by Rituximab Depends on CD20-Expression Level and Acts Complementary to Antibody-Dependent Cell-Mediated Cytotoxicity. van Meerten, Tom

106 11 p. 775
artikel
1228 Complete Absence of the Lineage-Determining Transcription Factor C/EBPα Results in Loss of Myeloid Identity in Bcr/abl Induced Malignancy. Wagner, Katharina

106 11 p. 646
artikel
1229 Complete Cytogenetic Response in a Case of T-PLL with a Complex Karyotype after Treatment with Alemtuzumab. Marinato, André F.

106 11 p. 4535
artikel
1230 Complete Eradication of Minimal Residual Disease (MRD) in Patients with Hairy Cell Leukemia (HCL) after Cladribine (2CDA) Followed by an Extended Course of Rituximab. Ravandi-Kashani, Farhad

106 11 p. 3258
artikel
1231 Complete Loss or Severely Compromised Expression of the Pro-Apoptotic Protein Bax Leads to Resistance to Curcumin-Induced Apoptosis in Burkitt's Lymphoma Cells. Hussain, Azhar R.

106 11 p. 1928
artikel
1232 Complete Response (CR) with Total Therapy 2 (TT2) for Multiple Myeloma (MM): Low Frequency in Case of Prior MGUS without Adverse Consequences for Survival - Yet Critical for Disease Control in Presumed “De Novo” MM. Fassas, Athanasios

106 11 p. 1172
artikel
1233 Complete Reversion of Imatinib-Induced Hepatotoxicity in Chronic Myeloid Leukemia Patients by Low-Intermediate Dose Corticosteroid. Ferrero, Dario

106 11 p. 4856
artikel
1234 Completion of the First Cohort of Patients with Cutaneous T-Cell Lymphoma Enrolled on a Phase II Trial of Depsipeptide. Piekarz, Richard L.

106 11 p. 231
artikel
1235 Complex Aberrant Karyotypes and Unbalanced Translocations in CLL Correlate with an Unmutated IgVH Status: A Study on 133 Patients Studied with Chromosome Banding Analysis, Interphase FISH, IgVH Mutation Status, ZAP-70 RNA Expression and Immunophenotyping. Dicker, Frank

106 11 p. 2939
artikel
1236 Complex Functions of Gab2 and Gab3 in CSF-1-Dependent Signal Transduction. Mao, Yingwei

106 11 p. 2292
artikel
1237 Complex Karyotype in Patients with Chronic Lymphocytic Leukemia. Yañez, Lucrecia

106 11 p. 4989
artikel
1238 Complex Paterns of Monoclonal Ig Diversification in B-CLL Cells from Different Tissue Compartments. Dimitriadou, Evangelia M.

106 11 p. 5021
artikel
1239 Complex Regulation of the Homeobox Transcription Factor TGIF: Differential Expression of Multiple 5′ Isoforms. Hamid, Rizwan

106 11 p. 4254
artikel
1240 Complex Translocation (8;16;21); a New Variant of t(8;21), with t(13;22) in Acute Myeloid Leukemia. Gupta, Shiphali

106 11 p. 4342
artikel
1241 Compound GW506U78 Has High Single-Drug Activity and Good Feasibility in Heavily Pretreated Relapsed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LBL) and Offers the Option for Cure with Stem Cell Transplantation (SCT). Goekbuget, Nicola

106 11 p. 150
artikel
1242 Compound Heterozygeous RAG-1 Mutations in 2 Patients Presenting with Chronic Disfiguring Granulomatous Skin Lesions. Schuetz, Catharina

106 11 p. 3898
artikel
1243 Compound Heterozygosity for a Novel Mutation Combined with G Insertion in Exon 13 Causes Severe Factor XI Deficiency in Patients of Japanese Origin. Ishikawa, Nobutsune

106 11 p. 4087
artikel
1244 Compound Heterozygosity in the Novel Mutations W157R and T591K in the γ-Glutamyl Carboxylase Gene Causes Hereditary Combined Vitamin K-Dependent Coagulation Factor Deficiency in a Tunisian Family. Darghouth, Dhouha

106 11 p. 2147
artikel
1245 Comprehensive Analysis of CD8 T Cell Immune Response Specific for Two Novel HLA-A*0201 Restriced CMV pp65 Peptides. Bracci, Laura

106 11 p. 3928
artikel
1246 Comprehensive Analysis of Homeobox Gene Expression in Hodgkin Lymphoma Cell Lines Reveals Similarities to Prostate Carcinoma. Nagel, Stefan

106 11 p. 966
artikel
1247 Comprehensive Analysis of MHC Class I Peptides Presented on Adult T Cell Leukemia Cells by Mass-Spectrometry. Kawahara, Masahiro

106 11 p. 1479
artikel
1248 Comprehensive HOX Gene Expression Profiles Are Associated with Major Cytogenetic Prognostic Categories in AML. Drabkin, Harry A.

106 11 p. 2989
artikel
1249 Comprehensive Immune Reconstitution without Development of Graft Versus Host Disease (GvHD) Using Limited T-Cell Add Back at the Time of Unrelated Multi-Antigen Mismatched Pan-T-Cell Depleted Transplant. Friedman, Thea M.

106 11 p. 5383
artikel
1250 Comprehensive Promoter Methylation Analysis of Genes on 5q31.1 in MDS and AML. Oki, Yasuhiro

106 11 p. 3443
artikel
1251 Computed Tomography (CT) Scan Response Stability and Gallium Scan Evaluation as On-Treatment Prognostic Parameters To Tailor Treatment Intensity of Newly Diagnosed Hodgkin's Lymphoma (HL). A Prospective Phase II Study. Re, Alessandro

106 11 p. 2669
artikel
1252 Computerized Tomographic Pulmonary Angiography Compared with Ventilation-Perfusion Lung Scanning as Inital Diagnostic Modality for Patients with Suspected Pulmonary Embolism: A Randomized Controlled Trial. Anderson, David R.

106 11 p. 1619
artikel
1253 Concept, Feasibility and Results of the Randomized Comparison of Imatinib Combination Therapies for Chronic Myeloid Leukemia: The German CML-Study IV. Berger, Ute

106 11 p. 1083
artikel
1254 Conception and Pregnancy in Patients (pts) with Chronic Myeloid Leukemia (CML) Receiving Therapy with Imatinib Mesylate (IM). Ault, Pat

106 11 p. 1104
artikel
1255 Concomitant Administration of Recombinant Human Erythropoietin (rHuEPO) and Oral Iron Chelator Deferiprone May Stabilize Iron Balance in Transfusion Dependent Patients with Early Myelodysplastic Syndrome (MDS). Cermak, Jaroslav

106 11 p. 4901
artikel
1256 Concomitant Induction of CMVpp65-Specific CD4+ and CD8+ T Cells Using Dendritic Cells Transfected with mRNA Encoding an Invariant Chain-pp65 Fusion Protein. Le, Ngocdiep

106 11 p. 3243
artikel
1257 Conditional Inactivation of the Proto-Oncogene Pokemon Results in Block of Differentiation in Multiple Hematopoietic Lineages. Maeda, Takahiro

106 11 p. 121
artikel
1258 Conditional Survival of Patients with Diffuse Large B-Cell Lymphoma. Moller, Michael B.

106 11 p. 1911
artikel
1259 Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies. Turner, Brie E.

106 11 p. 3112
artikel
1260 Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation. Miesbach, Wolfgang A.

106 11 p. 2138
artikel
1261 Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation. Phillips, John D.

106 11 p. 515
artikel
1262 Consolidation of Chemotherapy Response in Mantle Cell Lymphoma (MCL) Patients with 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) Radioimmunotherapy (RIT). Jurczak, W.

106 11 p. 2453
artikel
1263 Constitutional Segmental Uniparental Disomy in a Twin Pair with t(12;21) Positive Acute Lymphoblastic Leukemia Characterized by the Same Prenatal Clone and Divergent Clonal Evolution. Cazzaniga, Giovanni

106 11 p. 4549
artikel
1264 Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma. Rudelius, Martina

106 11 p. 1908
artikel
1265 Constitutive Activation of SRC-Family Kinases in Chronic Myelogenous Leukemia Patients Resistant to Imatinib Mesylate in the Absence of BCR-ABL Mutations: A Rationale for Use of SRC/ABL Dual Kinase Inhibitor-Based Therapy. Donato, Nicholas J.

106 11 p. 1087
artikel
1266 Constitutive Activation of STAT5 and Bcl-XL Overexpression Can Induce Endogenous Erythroid Colony Formation in Human Primary Cells. Garçon, Loïc

106 11 p. 3135
artikel
1267 Constitutive Expression of Pax5 in Cord Blood Progenitor Cells Rather Inhibits B Lymphopoiesis as Well as Myelopoiesis through the Exon 9-Dependent and Independent Mechanism. Sekine, Rieko

106 11 p. 2718
artikel
1268 Constitutive Expression of the ABCG2 (BCRP), the Molecular Determinant of the Side Population, Increases the Proliferative Potential of Human Clonogenic Progenitors and Supports Human Myeloid Engraftment in the NOD/SCID Mouse Model. Ahmed, Farid

106 11 p. 799
artikel
1269 Constitutive Expression of the Granzyme B Inhibitor PI-9 Protects Leukemic Cells from Granzyme B Induced Apoptosis. Grullich, Carsten

106 11 p. 3030
artikel
1270 Constitutive Expression of the ‘Lymphoid Enhancer Factor 1‘ (Lef-1) Perturbs Early Hematopoietic Development and Induces a Lethal Myeloproliferative Syndrome in a Subset of Transplanted Mice. Petropoulos, Konstantin

106 11 p. 644
artikel
1271 Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment of Older AML Patients: First Results of a Multicenter Phase II Study. Lübbert, Michael

106 11 p. 1852
artikel
1272 Continuing Reduction in Level of Residual Disease after 4 Years in Patients with CML in Chronic Phase Responding to First-Line Imatinib (IM) in the IRIS Study. Goldman, John M.

106 11 p. 163
artikel
1273 Continuous Drip Infusion of Low Dose Cytrabine and Etoposide with Granulocyte Colony-Stimulating Factor for Elderly Acute Myeloid Leukemia Patients Hardly Tolerable Intensive Chemotherapy - Phase II Study. Kanemura, Nobuhiro

106 11 p. 1858
artikel
1274 Continuous Infusion/Subcutaneous Alemtuzumab (Campath-1H) Plus Rituximab Is Active for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL). Faderl, Stefan

106 11 p. 2963
artikel
1275 Contrasting Effects of Post-Transplant Lymphopenia on Proliferation and Degranulation in Antigen-Specific CD8 Memory T Cells. Shatry, Alwi M.

106 11 p. 66
artikel
1276 Contribution of Nucleic Acid Testing of Plasma Source Material to the Viral Safety of Plasma Derived Coagulation Factors: The French Experience. Visse, Catherine

106 11 p. 1899
artikel
1277 Control of Cell Death Levels Using Th9402-Based PDT Treatment on Fresh PBMC, and Potential Application to Patients with cGvHD. Levesque, Annie

106 11 p. 5258
artikel
1278 Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial. Walter, Patrick

106 11 p. 3598
artikel
1279 Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial. Bocchia, Monica

106 11 p. 167
artikel
1280 Conversion of Alloantigen-Specific CD8+ T-Cell Anergy to T-Cell Priming through In Vivo Ligation of Glucocorticoid-Induced Tumor Necrosis Factor Receptor. Kim, Hawk

106 11 p. 1315
artikel
1281 Converting Mixed Chimerism to Full Donor Chimerism in Recipients of Campath-Containing Reduced Intensity Transplants Reduces the Relapse Risk and Results in Significantly Improved Survival Compared to Those with Persistent Full Donor Chimerism. Shaw, Bronwen E.

106 11 p. 2026
artikel
1282 Cooperative Action of 1alpha,25-Dihydroxyvitamin D3 and Retinoic Acid in NB4 Acute Promyelocytic Leukemia Cell Differentiation Is Transcriptionally Controlled. Bastie, Jean-Noel

106 11 p. 4247
artikel
1283 Cooperative Silencing of Chicken ρ- and βH- Globin Gene Expression by Chicken β-Globin Regulatory Elements: Involvement of RNAi Mediated Repression. Epner, Elliot M.

106 11 p. 3627
artikel
1284 Coordination of Intrinsic, Extrinsic and Endoplasmic Reticulum-Mediated Apoptosis by Imatinib Mesylate Combined with Arsenic Trioxide in Chronic Myeloid Leukemia. Zhang, Ji

106 11 p. 4841
artikel
1285 Coping Styles and Health-Related Quality of Life in Children with Sickle Cell Disease. Panepinto, Julie A.

106 11 p. 1328
artikel
1286 Copper-Complexed Melphalan (MOC*M), a Member of a New Class of Anti-Leukemic and Anti-Tumouric Substances for Treatment of Primary and Relapsed Acute Lymphoblastic Leukemia in Childhood. Prokop, Aram

106 11 p. 4457
artikel
1287 Copper Deficiency Anemia Is Not Uncommon in a Hematology Practice. Huff, Jason D.

106 11 p. 1681
artikel
1288 Copper Deficiency Secondary to Bariatric Surgery Mimicking Myelodysplasia. Doshi, Vaishali R.

106 11 p. 4930
artikel
1289 Cord Blood Transplantation for Adult Acute Lymphoblastic Leukemia. Kawano, Tomomi

106 11 p. 5450
artikel
1290 Coronary Artery Damage Induces Endothelial Progenitor Cell Recruitment and High Levels of Circulating EPCs Correlate with Coronary Artery Collaterals Formation. Lev, Eli I.

106 11 p. 3682
artikel
1291 Correction of Murine Hemophilia A by Hematopoietic Stem Cell Gene Therapy. Hawley, Robert G.

106 11 p. 1291
artikel
1292 Correlation between Angiogenic and Coagulation-Fibrinolysis Factors and Stage of Disease in Non Hodgkin's Lymphoma Patients. Mazur, Grzegorz

106 11 p. 4678
artikel
1293 Correlation between Antifactor Xa Activity and Thrombin Generation Time, Platelet Contractile Force and Clot Elastic Modulus Following Enoxaparin Exposure in Patients with and without Renal Dysfunction. Brophy, Donald F.

106 11 p. 4144
artikel
1294 Correlation between Entothelial Microparticle Binding to Monocytes and Monocyte Nitric Oxide Production in Prothrombotic and Inflammatory Disorders. Chirinos, Julio A.

106 11 p. 3860
artikel
1295 Correlation between Helicobacter Pylori Eradication and Platelet Count in Immune Thrombocytopenic Purpura (ITP). Jang, Jun Ho

106 11 p. 4003
artikel
1296 Correlation between Tumor Uptake on Indium-111 Ibritumomab Tiuxetan Imaging and Size on CT to Disease Response on FDG PET/CT Scans Obtained Pre- and Post-Yttrium-90 Ibritumomab Tiuxetan Therapy for Non-Hodgkin Lymphoma. Alexnder, Jacob M.

106 11 p. 4781
artikel
1297 Correlation of Acute GVHD with CD4+CD25+ Regulatory T Cells of the Donates and Receipients in Allogeneic Hematopoietic Stem Cell Transplantation. Min, Zhai Zhi

106 11 p. 5235
artikel
1298 Correlation of Clinical Response to Dasatinib (BMS-354825) with BCR-ABL Mutation Status in Imatinib- Resistant Patients (pts) with Chronic Myeloid Leukemia (CML) Treated at MD Anderson Cancer Center (MDACC). Jabbour, Elias

106 11 p. 1091
artikel
1299 Correlation of Cytogenetic Findings with Morphology, Clinical Course and Prognosis in 2124 Patients with MDS. Haase, D.

106 11 p. 787
artikel
1300 Correlation of Different Responses to Imatinib on Survival of Patients (pts) with Chronic Myelogenous Leukemia (CML) in Accelerated (AP) and Blast Phase (BP). Aoki, Etsuko

106 11 p. 1103
artikel
1301 Correlation of JAK2 Mutation and PRV-1 and WT1 Transcript Amount in Myeloproliferative Disorders. Serra, Anna

106 11 p. 1206
artikel
1302 Correlation of Suppression of FDG PET Uptake with Serum Free Light Chain Levels - Both FDG PET-CT and Serum Clonal Free Light Chain Response Precede and Predict the Likelihood of Subsequent Complete Remission in Newly Diagnosed Multiple Myeloma. Walker, Ronald

106 11 p. 3493
artikel
1303 Corticosteroids and Increased Risk of Readmission after Acute Chest Syndrome. Strouse, John J.

106 11 p. 2329
artikel
1304 Cost-Effectiveness Analysis of Oral Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) Versus Infusional Chelation Therapy with Deferoxamine in Patients with Transfusion-Dependent Myelodysplastic Syndrome. Delea, Thomas E.

106 11 p. 5585
artikel
1305 Cost-Effectiveness of Itraconazole for the Prophylaxis of Invasive Fungal Infections for Neutropenic Patients; a Study for 3 European Countries. Postma, Maarten J.

106 11 p. 3133
artikel
1306 Cost-Effectiveness of Lenalidomide in the Treatment of Patients with Transfusion-Dependent Myelodysplastic Syndromes (MDS) in the United States. Goss, Thomas F.

106 11 p. 1338
artikel
1307 Cost-Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox (Exjade®, ICL670) Versus Infusional Deferoxamine in Transfusion-Dependent Thalassemic Patients. Delea, Thomas E.

106 11 p. 1341
artikel
1308 Cost-Effectiveness of 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) Versus Rituximab Monotherapy in Patients with Relapsed Follicular Lymphoma. Thompson, S.

106 11 p. 2436
artikel
1309 Costs and Consequences of Inadequate Compliance with Deferoxamine Therapy in Patients with Transfusion-Dependent Thalassemia. Delea, Thomas E.

106 11 p. 3134
artikel
1310 Costs of Care for Hospitalized Adults with Sickle Cell Anemia (SCA) in Maryland (MD) Have Skyrocketed: 1995–2003. Lanzkron, Sophie

106 11 p. 2237
artikel
1311 Co-Transplantation Haploidentical Mesenchymal Stem Cells and Hematoietic Stem Cells with Nonmyeloablative Condition for Treatment of Relapsed or Refractory Acute Leukaemia. Ai, Hui-Sheng

106 11 p. 5439
artikel
1312 Co-Transplantation of Stromal Cells Enhances Engraftment Ability of MDS-Derived Hematopoietic Precursors in NOD/SCID-b2microglobulin-Deficient (b2mnull) Mice. Kerbauy, Daniella B.

106 11 p. 3429
artikel
1313 Co-Treatment with a Novel Heat Shock Protein (hsp) 90 Inhibitor IPI504 and the Histone Deacetylase Inhibitor (HDI) Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA): A Highly Active Combination Against Wild Type or Mutant Bcr-Abl-T315I or FLT-3-ITD-Containing Human Leukemia Cells. Fiskus, Warren

106 11 p. 4461
artikel
1314 Co-Treatment with the hsp90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (DMAG) and Histone Deacetylase Inhibitor (HDI) Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA): A Highly Active Combination Against Human Mantle Cell Lymphoma (MCL) Cells. Hatter, Angela

106 11 p. 2418
artikel
1315 Counterfeit Epoetin: A Review of MedWatch Data. Raisch, Dennis W.

106 11 p. 2251
artikel
1316 Coupling Tissue Type Plasminogen Activator to Carrier Erythrocyte Protects Against Plasma Inhibitors. Ganguly, Kumkum

106 11 p. 1881
artikel
1317 CpG in the Immunotherapy of B-Cell Lymphoma. Li, Jiali

106 11 p. 344
artikel
1318 CpG Island Methylation Is a Poor Prognostic Factors in Myelodysplastic Syndrome Patients and Is Reversed by Decitabine Therapy-Results of a Phase III Randomized Study. Shen, Lanlan

106 11 p. 790
artikel
1319 CpG Oligonucleotide (1018 ISS) May Overcome Rituximab (R) Resistance in Follicular Lymphoma (FL) through Enhanced ADCC, T Cell Expansion, and Alteration of Tumor Microenvironment. Friedberg, Jonathan W.

106 11 p. 2434
artikel
1320 C6PS Regulates the Inactivation of Factor Va by Activated Protein C. Majumder, Rinku

106 11 p. 1023
artikel
1321 Creatinine Clearance in Sickle Cell Anemia Is Modulated by Genes in the TGF-β/BMP Pathway. Nolan, Vikki G.

106 11 p. 3175
artikel
1322 Creation of a Ribosomal Protein Sa/LAMR1 Heterozygous Mouse. Ellis, Steven R.

106 11 p. 3551
artikel
1323 CREB Transgenic Mice Develop Myeloproliferative Disease/Myelodysplastic Syndrome after a Prolonged Latency. Shankar, Deepa B.

106 11 p. 367
artikel
1324 Critical Importance of Conventional Cytogenetics in Detecting Prognostically Significant Chromosome 13 Deletions in Myeloma. Chiecchio, Laura

106 11 p. 1544
artikel
1325 Critical Role for CCR1:CCL5 (RANTES) Receptor Ligand Interactions in Modulating Allogeneic T Cell Responses Following Bone Marrow Transplantation. Choi, Sung Won

106 11 p. 3107
artikel
1326 Critical Role of Endogenous ADP Via P2Y12 Receptor in Maintenance of αIibβ3 Activation. Kamae, Tsuyoshi

106 11 p. 1655
artikel
1327 Critical Role of flt3 in Fetal and Adult T Lymphopoiesis. Sitnicka, Ewa

106 11 p. 339
artikel
1328 Critical Role of the Blood Coagulation in Malaria: Plasmodium falciparum-Infected Red Blood Cells Induce Tissue Factor Expression by Endothelial Cells and Support the Assembly of Coagulation Complexes. Francischetti, Ivo M.B.

106 11 p. 4044
artikel
1329 CrkL Mediates SDF-1-Induced Chemotaxis through Ras, Rac, and Erk Activation in Hematopoietic Cells. Arai, Ayako

106 11 p. 2290
artikel
1330 Cross Talk between IRAK4 and the NADPH Oxidase. Catz, Sergio D.

106 11 p. 3081
artikel
1331 Cross Talk between Rho GTPases Is Critical for Hematopoietic-Derived Inflammatory Processes. Filippi, Marie-Dominique

106 11 p. 631
artikel
1332 Cross-Talk between Rho GTPases Regulates Actin Cytoskeleton and Chemotaxis of Hematopoietic Progenitor Cell. Chae, Hee-Don

106 11 p. 266
artikel
1333 Cryptic MLL, AF10, ARMC3 Rearrangement in Secondary AML Creates ARMC3-MLL Fusion That Disrupts Gene Encoding Armadillo Repeats Similar to Major Cancer Genes. Germano, Giuseppe

106 11 p. 4345
artikel
1334 Crystal Structure of the Interaction of Human Urokinase Plasminogen Activitor with Its Receptor. Huai, Qing

106 11 p. 683
artikel
1335 CTCF and Nucleophosmin Mediate Long Distance Cyclin D1 Deregulation in t(11;14) B Cell Malignancies. Epner, Elliot M.

106 11 p. 742
artikel
1336 CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia. Sala-Torra, Olga

106 11 p. 336
artikel
1337 CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients. Cho, Hearn J.

106 11 p. 356
artikel
1338 Cucurbitacins, a Family of Natural Compounds That Effectively Disrupt Stat3 Signaling in Antigen-Presenting Cells (APCs) Are Promising Agents To Overcome Tumor-Induced CD4+ T-Cell Tolerance. Cheng, Fengdong

106 11 p. 1485
artikel
1339 CUL-4A Short Hairpin RNA (shRNA) Impairs Normal Hematopoiesis of Human Cord Blood CD34+ Cells In Vitro and In Vivo. Shieh, Jae Hung

106 11 p. 2270
artikel
1340 CUL-4A Targets p27 for Degradation and Regulates Proliferation, Cell Cycle Exit, and Differentiation during Erythropoiesis. Chun, Kristin T.

106 11 p. 1358
artikel
1341 Cultured CD41a+ Megakaryocytes Derived from Cord Blood CD34+ Cells Are Activated Via STAT5 but Not STAT3. Smith, Stephen

106 11 p. 4240
artikel
1342 Culture-Expanded Human Bone Marrow Stromal Stem Cells Organize Functional Bone Marrow Niches In Vivo. Miura, Yasuo

106 11 p. 2314
artikel
1343 Culture of CD34+ Umbilical Cord Blood Progenitors with Notch Ligand Results in Enhanced and More Rapid Human Engraftment in a Preclinical NOD/SCID Mouse Model. Delaney, Colleen

106 11 p. 190
artikel
1344 Curcumin Enhances Differentiation of All-Trans Retinoic Acid (ATRA)-Sensitive and ATRA-Resistant Acute Promyelocytic (APL) Cells. Kini, Ameet R.

106 11 p. 4456
artikel
1345 Curcumin Induces Apoptosis by Inhibiting the Expression of IAPs in Human Precursor B-Acute Lymphoblastic Leukemic (PreB-ALL) Cells. Hussain, Azhar R.

106 11 p. 883
artikel
1346 CXCR4 Antagonists Mobilize Acute Lymphoblastic Leukemia Cells into the Peripheral Blood and Inhibit Engraftment in Mice. Juarez, Julius

106 11 p. 4592
artikel
1347 CyclinA2 as a Proliferation Marker for Peripheral Blood T Cell Subsets Measured by Flow Cytometry. Smith, Cecilia U.

106 11 p. 3324
artikel
1348 Cyclin-Dependent Kinases Phosphorylate AML1 (RUNX1) and Regulate AML1 Transactivation. Biggs, Joseph R.

106 11 p. 2721
artikel
1349 Cyclin D3 Is Required for Peritoneal B-1a Lymphocyte Proliferation. Mataraza, Jennifer M.

106 11 p. 1353
artikel
1350 Cyclin D1 Mediates Resistance towards p53-Independent and -Dependent Apoptosis through Anti-Apoptotic Factors and Molecular Chaperones. Roue, Gael

106 11 p. 4294
artikel
1351 Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Transplanted for Multiple Myeloma. Dingli, David

106 11 p. 1165
artikel
1352 Cyclosporine Alone for the Treatment of Early Recurrences of TTP. Cataland, Spero R.

106 11 p. 1236
artikel
1353 Cyclosporine and Plasma Exchange Is Superior to Corticosteroids and Plasma Exchange as Initial Therapy of TTP. Cataland, Spero R.

106 11 p. 1235
artikel
1354 Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study. Chen, Allen

106 11 p. 2087
artikel
1355 Cycloxygenase-2 (COX-2) Expression Is More in Clonal Plasma Cells. Paneesha, S.

106 11 p. 5103
artikel
1356 Cytogenetic Abnormalities in B-CLL at Binet Stage A: Overview in a Cohort of 484 Untreated Patients and Relations with the ZAP-70 and IgVH Mutation Status. Nguyen-Khac, Florence

106 11 p. 2950
artikel
1357 Cytogenetic Abnormalities in Histologically Confirmed Multiple Myeloma. Mohamed, Anwar N.

106 11 p. 5082
artikel
1358 Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML). Kalaycio, Matt

106 11 p. 4500
artikel
1359 Cytogenetic Clonal Evolution in Chronic Myeloid Leukemia during Imatinib Mesylate Treatment. Klamova, Hana

106 11 p. 4844
artikel
1360 Cytogenetic Profile, JAK2V617F Mutational Status, and Response to Drug Therapy in Myelofibrosis with Myeloid Metaplasia. Strand, Jacob J.

106 11 p. 2591
artikel
1361 Cytogenetics and De Novo/Secondary AML but Not Age Are the Main Determinants for CR Rate and Hematological Recovery in Acute Myeloid Leukemia (AML) Using Intermediate Doses of Cytarabine (AraC) Delivered at the Presumptive Saturating Infusion Rate. Becker, Cornelia

106 11 p. 1851
artikel
1362 Cytogenetics in Adult De Novo Acute Myeloid Leukemia: An Institutional Experience of a Predominantly Minority Population. Berko, Ebenezer

106 11 p. 4484
artikel
1363 Cytogenetics in Pediatric MDS - Data of the EWOG-MDS 98 Study. Michalova, K.

106 11 p. 4914
artikel
1364 Cytogenetics of Hispanics and Whites with Childhood Acute Lymphoblastic Leukemia in California. Aldrich, Melinda C.

106 11 p. 4536
artikel
1365 Cytogenetics of 125 Untreated Patients with Binet Stages B or C B-CLL. Preliminary Results of a Multicentric Study from the French Cooperative Study Group on CLL. Nguyen-Khac, Florence

106 11 p. 5003
artikel
1366 Cytogenetic Studies of 539 Chronic Lymphocytic Leukemia (CLL) Patients. Heerema, Nyla A.

106 11 p. 1192
artikel
1367 Cytokine Exposure Changes the Hierarchy of Molecular Pathway Usage in Bone Marrow Homing. Boenig, Halvard

106 11 p. 3161
artikel
1368 Cytokine Gene Expression in Peripheral Blood Mononuclear Cells Points to Interleukin-10 as an Inhibitor of Alloreactivity Following Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning. Petersen, Soren L.

106 11 p. 5342
artikel
1369 Cytokine Gene Expression Profile Distinguishes CD4+/CD57+ T-Cells of Nodular Lymphocyte Predominance Type of Hodgkin Lymphoma from Their Tonsillar Counterparts. van den Berg, Anke

106 11 p. 973
artikel
1370 Cytokine Gene Polymorphisms in Turkish Patients with Childhood Chronic Myeloid Leukemia. Ozdilli, Kursat

106 11 p. 4368
artikel
1371 Cytokine Induced Changes in the Hematopoietic Stem Cell Trafficking Regulatory Peptidase CD26. Christopherson, Kent W.

106 11 p. 5220
artikel
1372 Cytokine Proteome of Terminally Differentiated Effector T Cells and Their Malignant Counterparts in T-LGL. Distinct Changes Consistent with Response to a Viral Pathogen. Wlodarski, Marcin W.

106 11 p. 2228
artikel
1373 Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit. Johnston, Amanda J.

106 11 p. 5374
artikel
1374 Cytoplasmic Tail of Tissue Factor(TF): Role in TF Trafficking to Microparticles. Zakarija, Anaadriana

106 11 p. 1936
artikel
1375 Cytosolic Histone H1.2 Releasing under Different Apoptotic Stimuli in Chronic Lymphocytic Leukemia (CLL). Gine, Eva

106 11 p. 2108
artikel
1376 Cytotoxic Activity of the Proteasome Inhibitor MLN-273 but Not of Bortezomib Is Inhibited by MDR1. Rumpold, Holger

106 11 p. 4467
artikel
1377 Cytotoxic Effect of R-Etodolac (SDX-101) in Combination with Purine Analogues or Monoclonal Antibodies on Ex-Vivo B-Cell Chronic Lymphocytic Leukemia Cells. Robak, Pawel

106 11 p. 2122
artikel
1378 Daclizumab-Associated Erythroderma Is Associated with Rebound Increases in CD25-Positive CD4 Cells Following Treatment of Aplastic Anemia and Pure Red Cell Aplasia. Lemery, Steven J.

106 11 p. 1042
artikel
1379 Daily Monitoring of Cyclosporine (Csa) Allows Better Control of Graft vs. Leukaemia Effect (GvL): Single Centre Experience. Das, Mayukh

106 11 p. 5319
artikel
1380 Danazol Stimulates Proplatelet Formation of Megakaryocytes Via Rac Activation Pathway. Murai, Kazunori

106 11 p. 4276
artikel
1381 DAP10 Costimulates Chimeric Receptor-Mediated T Cell Responses to Tumor Antigen. Altvater, Bianca

106 11 p. 3052
artikel
1382 Daptomycin (DAP) Use in Patients with Hematologic (HEM) Cancer History; Post-Marketing Experience in a Registry. Akpek, Gorgun

106 11 p. 3132
artikel
1383 Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome. Giraldo, Pilar

106 11 p. 2542
artikel
1384 Dasatinib (BMS-354825), a Multi-Targeted Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane and Activation Loop Mutant Kit Isoforms Associated with Human Malignancies. Schittenhelm, Marcus M.

106 11 p. 3358
artikel
1385 Dasatinib (BMS-354825): A Multi-Targeted Kinase Inhibitor with Activity Against Multiple Myeloma. Deng, Qingwei

106 11 p. 1571
artikel
1386 Dasatinib (BMS-354825) Has Increased Activity Against Bcr-Abl Compared to Imatinib in Primary CML Cells In Vitro, but Does Not Eradicate Quiescent CML Stem Cells. Copland, Mhairi

106 11 p. 695
artikel
1387 Dasatinib (BMS-354825) in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib: Update of a Phase I Study. Sawyers, Charles L.

106 11 p. 38
artikel
1388 Dasatinib (BMS-354825) Overcomes Multiple Mechanisms of Imatinib Resistance in Chronic Myeloid Leukemia (CML). Lee, Francis Y.

106 11 p. 1994
artikel
1389 Data Visualization of Multiparameter Information in Acute Lymphoblastic Leukemia Expands the Ability To Explore Prognostic Factors. Ragg, Susanne

106 11 p. 862
artikel
1390 Daunorubicin Dose Intensification during Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Final Results from Cancer and Leukemia Group B Study 19802. Stock, Wendy

106 11 p. 1833
artikel
1391 DDAVP at a Maximal Dose of 15 ug Administered Subcutaneously Is a Safe and Effective Alternative to 20 ug IV for Patients > 50 kg with von Willebrand Disease or Mild Hemophilia A. Mangel, Joy

106 11 p. 1793
artikel
1392 D Dimer Levels Are Markedly Raised in HIV-Related TTP. Gunther, Karen E.

106 11 p. 2173
artikel
1393 Death-Associated Protein Kinase-2 (DAPK2) Potentiates Erythroid Progenitor Cell Apoptosis in Response to Cisplatin, and Cytokine Withdrawal. Fang, Jing

106 11 p. 3537
artikel
1394 Decitabine, a Potential Targeted Therapeutic for Juvenile Myelomonocytic Leukemia. Liu, Y. Lucy

106 11 p. 2516
artikel
1395 Decitabine Low-Dose Schedule (100 mg/m2/Course) in Myelodysplastic Syndrome (MDS). Comparison of 3 Different Dose Schedules. Kantarjian, Hagop

106 11 p. 2522
artikel
1396 Decitabine: Where Is the Target?. Tamm, Ingo

106 11 p. 495
artikel
1397 Decreased Generation and Function of CD4+CD25hi T Regulatory Cells in Human STAT5b Deficiency. Cleary, Aileen

106 11 p. 768
artikel
1398 Decreased Incidence of Relapse in Patients with Acute Leukemia Transplanted from Matched Unrelated Donors: Induction of GvL. Arellano, Martha L.

106 11 p. 2016
artikel
1399 Decreased Responsiveness of Mature Dendritic Cells from Cord Blood to Chemotaxis Induced by CXCR4 Ligand CXCL12, and CCR7 Ligand CCL19 May Explain Lowered GVHD Associated with Cord Blood Tranplantation. Li, Geling

106 11 p. 766
artikel
1400 Decreased TCR ζ-Chain Expression in T Cells from Patients with Aplastic Anemia. Solomou, Elena E.

106 11 p. 3916
artikel
1401 Decrease of FoxP3 Gene Expression Precedes and Inversely Correlates with Onset of Acute GVHD. Tabellini, Laura

106 11 p. 1419
artikel
1402 Deep Vein Thrombosis during Pregnancy in Double Homozygous Carrier of Factor V Leiden and Prothrombin G20210A. Martinelli, Ida

106 11 p. 1633
artikel
1403 Defective Cell Cycle Induction by IL-2 in Naïve T-Cells Antigen-Stimulated in the Presence of Refractory T-Lymphocytes. Inaba, Hiroto

106 11 p. 3298
artikel
1404 Defective Engraftment of HSPC from C3aR−/ − Mice Reveals an Underappreciated Role of C3a-C3aR Axis in Stem Cell Homing to Bone Marrow. Reca, Ryan

106 11 p. 1259
artikel
1405 Defective Modification of Mannose Residues by Terminal Phosphoethanolamine Underlies Inherited GPI Deficiency. Almeida, A.M.

106 11 p. 128
artikel
1406 Defective Recycling and Exocytosis of Transferrin in Reticulocytes of hbd (Hemoglobin Deficit) Mice. Garrick, Michael D.

106 11 p. 3726
artikel
1407 Defective Regulated Exocytosis in Mast Cells from Synaptotagmin-2 Knockout Mice. Sansores-Garcia, Leticia

106 11 p. 3090
artikel
1408 Defective Ribosomal Protein Gene Expression Alters Transcription, Translation and Oncogenic Pathways in Diamond-Blackfan Anemia. Gazda, Hanna T.

106 11 p. 3546
artikel
1409 Defects in Management of Labile Iron and Oxidative Stress Underpin Red Cell Enucleation Defects in Rb Null Mice. Macleod, Kay F.

106 11 p. 1351
artikel
1410 Defects of the Tpo-Receptor, Mpl, Caused by Mutations Found in CAMT Patients. Tijssen, Marloes R.

106 11 p. 2181
artikel
1411 Deferasirox (Exjade®, ICL670): A Journey into Labile Iron Centers of Living Cardiomyocytes. Cabantchik, Z.I.

106 11 p. 824
artikel
1412 Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia. Greenberg, P.

106 11 p. 2694
artikel
1413 Deferasirox (Exjade®, ICL670) Demonstrates Iron Chelating Efficacy Related to Transfusional Iron Intake in Pediatric Patients. Kattamis, C.

106 11 p. 2692
artikel
1414 Deferasirox (Exjade®, ICL670) Treatment of Inadequately Chelated β-Thalassemia Patients from the Middle East: The ESCALATOR Trial. Taher, Ali

106 11 p. 3840
artikel
1415 Defibrotide, an Endothelium Protecting and Stabilizing Drug, Has Anti-Angiogenic Potential In Vitro and In Vivo. Eissner, Guenther

106 11 p. 3956
artikel
1416 Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF. Richardson, Paul G.

106 11 p. 399
artikel
1417 Deficiency of 2,3-Dimethoxy-5-Methyl-6-Decaprenyl-1,4-Benzoquinone (Mitoquinone) and Hyperlactic Acidosis in Human Immunodeficiency Virus (HIV) Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Based HAART and Chemoradiation. McPherson, Eugene

106 11 p. 3899
artikel
1418 Deficient Ribosomal Protein S19 in Diamond-Blackfan Anemia Causes a Reduction in bcl-2 and Bad and Leads to Apoptosis in Erythroid Progenitor Cells. Miyake, Koichi

106 11 p. 131
artikel
1419 Defining Candidate Oncogenes Leading to Increased Susceptibility to Leukemia in eed Mutant Mice. Sauvageau, Martin

106 11 p. 2622
artikel
1420 Defining Second-Hit Genetic Abnormalities Involved in the t(12; 21) TEL-AML1 Acute Lymphoblastic Leukemia by Array-Based Comparative Genomic Hybridization. Tsuzuki, Shinobu

106 11 p. 2845
artikel
1421 Definition of Cytochrome P450 1A2 as a Target Autoantigen in the Hepatitic Variant of Hepatic Chronic Graft-Versus-Host Disease. Mullighan, Charles G.

106 11 p. 1421
artikel
1422 Delayed Hepatitis B Active Viral Replications without Active Viral Biochemical Hepatitis Two Months after Cessation of Pre-Emptive Adefovir Therapy in a Patient with Waldenstrom Macroglobulinemia Treated with Rituximab and Fludarabine Chemotherapy. Hanbali, Amr S.

106 11 p. 4770
artikel
1423 Delayed Infusion of Allogeneic Stem Cells (72 Hours) Does Not Reduce the Severity of Acute Graft Versus Host Disease in Patients with Chronic Myeloid Leukemia after Myeloablative Conditioning Regimen. Zaucha, Jan Maciej

106 11 p. 5382
artikel
1424 Delayed-Onset Heparin-Induced Thrombocytopenia and/or Thrombosis Following Open Heart Surgery Hospital Discharge. Frame, James N.

106 11 p. 1239
artikel
1425 Delayed Platelet Recovery Following Cord Blood Transplantation: Insights from a Mouse Model. Du, Tao

106 11 p. 1727
artikel
1426 Delayed Treatment of Bleeding in Patients with Mild Hemophilia Can Very Significantly Affect Overall Need for Therapy. Goodyear, D.

106 11 p. 4049
artikel
1427 Delayed Versus Initial Risk-Categorization of Pediatric Cancer Patients with Prolonged Febrile Neutropenia. A Randomized, Prospective Clinical Trial. Ahmed, Nabil M.

106 11 p. 3119
artikel
1428 Delayed Wound Healing in Hemophilia B Mice. Hoffman, Maureane

106 11 p. 3199
artikel
1429 Deletion of Any of BCR or ABL Gene on Derivative Chromosome 9 Is a Poor Prognostic Marker That Indicates Rapid Disease Progression in Chronic Myelogenous Leukemia. Lee, Young Kyung

106 11 p. 4471
artikel
1430 Deletion of p53 as Detected by Fluorescence In Situ Hybridization Is Associated with Significant Shorter Event-Free Survival in Patients with Multiple Myeloma Who Are Receiving Allogeneic Blood Stem Cell Transplantation. Schilling, Georgia

106 11 p. 4338
artikel
1431 Deletion of Tumor Suppressor Genes (TSGS) in Patients with Myelodysplastic Syndrome (MDS). Galanopoulos, Athanasios G.

106 11 p. 4907
artikel
1432 Delivery and Toxicity of Fludarabine-Based Combination Chemotherapy Regimens in Older Patients. Polizzotto, Mark N.

106 11 p. 3329
artikel
1433 Delivery of Autologous Bone Marrow Precursor Cells into the Spinal Cord Via Lumbar Puncture Technique in Patients with Spinal Cord Injury. Callera, Fernando

106 11 p. 5204
artikel
1434 Delta-1 Promotes Soluble IL-6R-Mediated Action of IL-6 on Human Erythropoiesis While Counteracting the Effect of IL-6 on the Generation of Myeloid-Lineage Cells. Yamamura, Kentaro

106 11 p. 3143
artikel
1435 Demethylation of βA-Globin Gene in Avian Primary Erythroid Cells Is Developmentally Regulated, Strand Asymmetrical and an Active Process. Ramachandran, Kavitha

106 11 p. 3647
artikel
1436 Demethylation Profiling of CD34-Positive Hematopoietic Cells in Patients with Myelodysplastic Syndromes. D'Alo', Francesco

106 11 p. 3440
artikel
1437 Denaturing- HPLC and HR-1 Melter-Based Detection of ABL Mutations in Patients with Chronic Myelogenous Leukemia (CML). Lee, Il-Kwon

106 11 p. 4876
artikel
1438 Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib. Guarini, Anna

106 11 p. 1835
artikel
1439 Dendritic Cell Deficiencies in Pediatric Acute Lymphoblastic Leukemia Patients. Maecker, Britta

106 11 p. 846
artikel
1440 Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant for Multiple Myeloma. Schlueter, Annette J.

106 11 p. 5212
artikel
1441 Dendritic Cells Reconstitution after Different Allogeneic Hematopoietic Stem Cell Transplantation. Wu, De Pei

106 11 p. 5211
artikel
1442 Dendritic Cells Recovery and Chimerism after Reduced Intensity Hematopoietic Stem Cell Transplantation. Tabrizi, Reza

106 11 p. 5341
artikel
1443 Dendritic Cell Vaccination Induces HCMV Specific T-Cell Responses in Allogeneic Stem Cell Recipients. Grigoleit, Ulrich

106 11 p. 475
artikel
1444 Dendritic Cell Vaccines Are Superior to Idiotype-KLH Protein Vaccines at Priming a Therapeutic, Tumor-Specific Immunity Against Multiple Myeloma. Yi, Qing

106 11 p. 3466
artikel
1445 Depletion of NUP98: A Common Leukemogenetic Mechanism in AML? Plasilova, Magdalena

106 11 p. 667
artikel
1446 Depletion of the Leukemic Fusion Protein MLL-AF4 with Short Interfering RNAs (siRNAs) Affects Post-Translational Modification of Aldolase A. Greil, Johann

106 11 p. 4341
artikel
1447 Depolymerized Holothurian Glycosaminoglycan and Heparin Inhibit the Intrinsic Tenase Complex by a Common Antithrombin-Independent Mechanism. Sheehan, John P.

106 11 p. 1011
artikel
1448 Depsipeptide (FK228) Preferentially Induces Apoptosis in BCR/ABL-Expressing TF-1 Cells. Okabe, Seiichi

106 11 p. 4845
artikel
1449 Deregulation of Retinoic Inducible Gene---Rig-I Underlies the Pathogenesis of Acute Promyelocytic Leukemia. Zhu, Jiang

106 11 p. 1606
artikel
1450 Derivation of Lymphoid Lineage Cells from Human Embryonic Stem Cells on Co-Culture in OP9 and OP9DL1 Stromal Cells. Mojica-Henshaw, Mariluz P.

106 11 p. 3619
artikel
1451 Derivative (1) t(1;1) (p36; q21) Produces the Fusion Protein with Phosphatase 10 and MEL1 (MDS1/EVI1-Like Gene 1) in a AML (M5a) Case. Noguchi, Mitsuho

106 11 p. 4336
artikel
1452 Detectable Minimal Residual Disease before Haematopoietic Stem Cell Transplantation Predicts Extremely Poor Prognosis in Children with Acute Lymphoblastic Leukaemia. Muzikova, Katerina

106 11 p. 2037
artikel
1453 Detection and Mechanisms of GPIIb-IIIa Antagonist Induced Thrombocytopenia: Role for Antibody Induced Platelet Activation. Linden, Matthew D.

106 11 p. 1654
artikel
1454 Detection of a CD133+/CD38− SL-IC Population in Childhood B Cell Precursor ALL. Cox, Charlotte V.

106 11 p. 1369
artikel
1455 Detection of Activated STAT5 in Neoplastic Mast Cells in Patients with Systemic Mastocytosis: Role of c-kit D816V. Sonneck, Karoline

106 11 p. 3515
artikel
1456 Detection of Aspergillus Species in Blood of Malignant Hemotopoietic Tumor Patients by Two-Step PCR. Qian, Wenbin

106 11 p. 4626
artikel
1457 Detection of a T Cell Clone in the Peripheral Blood at Diagnosis and in the Skin in Complete Clinical Remission after PUVA and Interferon-α Combination Therapy Is Not a Negative Prognostic Factor in Early Mycosis Fungoides. Gaia, Goteri

106 11 p. 2820
artikel
1458 Detection of Cytomegalovirus Specific Cytotoxic T Lymphocyte in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Sun, Jing

106 11 p. 5345
artikel
1459 Detection of JAK2 V617F in the Diagnosis of Erythrocytosis: Feasibility and Diagnostic Value in Clinical Practice. James, Chloé

106 11 p. 2595
artikel
1460 Detection of Microdeletions and Amplifications in Primary Human Acute Myeloid Leukemia (AML) Genomes Using Ultradense Oligomer Tiling Path Arrays and Comparative Genomic Hybridization (CGH). Walter, Matthew J.

106 11 p. 2350
artikel
1461 Detection of Minimal Residual Disease in Precursor B Lymphoblastic Leukemia (B-ALL) Patients by a Novel Epigenetic DNA Methylation Biomarker. Wang, Michael X.

106 11 p. 4524
artikel
1462 Detection of p53 Protein in Leukemic Cells by Flow Cytometry. Cavalcanti Junior, Geraldo B.

106 11 p. 4537
artikel
1463 Detection of Proteins Related to Therapeutic Outcome, Including Drug Resistance, in Acute Myeloid Leukemia Using Mass Spectrometry and Gel Based Proteomic Profiling. Stenke, Leif

106 11 p. 2367
artikel
1464 Detection of sjTRECs within Peripheral Blood T Cells Evaluation of Recent Thymic Output Function in Myelodysplastic Syndrome. Du, Xin

106 11 p. 4919
artikel
1465 Detection of 24 TCR Vβ-Dβ1 sjTRECs in T Cells from Cord Blood, Peripheral Blood of Normal Individuals and Patients with AML-M2. Li, Yangqiu

106 11 p. 4557
artikel
1466 Detection of the Acquired Tyrosine Kinase JAK2 Gene Mutation by Real Time PCR as Minimal Residual Disease Marker for Patients after Allogeneic Hematopoetic Stem Cell Transplantation. Elmaagacli, Ahmet H.

106 11 p. 1212
artikel
1467 Detection of the NUP214-ABL Rearrangement in T-ALL by High-Density Oligonucleotide Arrays: Evidence of the Value of This Approach in the Identification of Gene Amplifications. Chiaretti, Sabina

106 11 p. 1211
artikel
1468 Detection the Expression of Notch and Its Related Molecules in Bone Marrow Cells of Acute Leukemia Patients by Quantitative Real-Time RT-PCR. Zhou, Ya-nan

106 11 p. 4369
artikel
1469 Determinants of Health-Related Quality of Life after Deep Venous Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study). Kahn, Susan R.

106 11 p. 585
artikel
1470 Determinants of Thrombophilia in an Urban Systemic Lupus Erythematosus Population. Andersen, Judith C.

106 11 p. 4134
artikel
1471 Determination of a HLA II Promiscuous Peptide Cocktail as Potential Vaccine Against EBV Latency II Malignancies. Depil, Stephane

106 11 p. 1478
artikel
1472 Determining the Benefits of Chemotherapy for Achieving Complete Response in Patients with Untreated Advanced Stage Follicular Lymphoma: A Systematic Review and Meta-Analysis. Orina, Josiah N.

106 11 p. 290
artikel
1473 Deterministic Trigger of Self-Renewal in Expanded HSCs Expressing Hoxb4 + Antisense Pbx1. Cellot, Sonia

106 11 p. 800
artikel
1474 Developing an Algorithm for Monitoring Chimerism after Allogeneic Bone Marrow Transplantation - A Single Centre Experience. Chandy, Mammen

106 11 p. 5301
artikel
1475 Developmental and Differential Changes of Gene Expression in Erythroid Progenitor Cells. Cokic, Vladan P.

106 11 p. 3648
artikel
1476 Developmental Plasticity Revealed by Lineage Switch from Committed Megakaryocytic Cells to Granulocytic Cells. Miller, William M.

106 11 p. 3610
artikel
1477 Development and Clinical Validation of a “Home-Brew” Dual-Color FISH Probe Assay To Differentiate between ELL and ENL Gene Rearrangements in Leukemia. Biggerstaff, Julie A. Sanford

106 11 p. 3268
artikel
1478 Development and Immunologic Characterization of Multi-Antigen Expressing Attenuated Poxviruses for Immunotherapy of CMV Infection in HSCT Recipients. Diamond, Don J.

106 11 p. 480
artikel
1479 Development and Performance of the GTI ADAMTS-13 Activity Assay. Pressman, Melissa A.

106 11 p. 4097
artikel
1480 Development of a BCR/ABL Real-Time Quantitative RT-PCR Assay and Correlation with an Existing Qualitative Test. Howe, John Greg

106 11 p. 4879
artikel
1481 Development of a Blastoid Variant, Mantle Cell Lymphoma Model in Transgenic Mice. Ford, Richard J.

106 11 p. 419
artikel
1482 Development of a Measure of Health-Related Quality of Life for Non-Hodgkin's Lymphoma Clinical Research: The Functional Assessment of Cancer Therapy - Lymphoma (FACT-Lym). Cella, David

106 11 p. 750
artikel
1483 Development of a Model for the Study of PU.1 Function in Primary Human Hematopoietic Cells. Durual, Stephane

106 11 p. 4234
artikel
1484 Development of a New Experimental Animal Model of Human Megakaryopoiesis Using Immunodeficient NOD/Shi-scid, IL-2Rγnull (NOG) Mice. Miyakawa, Yoshitaka

106 11 p. 4266
artikel
1485 Development of an In Vivo Exon Trapping Vector System To Detect Insertional Gene Activation by Lentiviral Vector. Hanawa, Hideki

106 11 p. 3059
artikel
1486 Development of a Nonhuman Primate Model for Analysis of the Adoptive Transfer of Antigen-Specific T Cell Clones. Berger, Carolina

106 11 p. 770
artikel
1487 Development of a Novel Assay Using Bioluminescent Reporter Bacteria To Determine the Sensitivity of AML Cells to Cytosine Arabinoside. Smith, Graham

106 11 p. 2473
artikel
1488 Development of a Panel of 3,500 SNP Based Functional Genetic Variants Relevant to the Etiology and Outcome in Multiple Myeloma. Johnson, David C.

106 11 p. 620
artikel
1489 Development of B Cell Lymphoma in Eμ-Cyclin D1 X Mutant p53 Transgenic Mice. Smith, Mitchell R.

106 11 p. 1907
artikel
1490 Development of Clinical Scale Cytomegalovirus-Specific T Cells for Adoptive Immunotherapy Using pp65. Diamanti, Paraskevi

106 11 p. 5250
artikel
1491 Development of Dendritic Cell Vaccine Against Measles for Patients Following Hematopoietic Cell Transplantation. Kumamoto, Tadashi

106 11 p. 476
artikel
1492 Development of Forodesine Hydrochloride (FH), an Inhibitor of Purine Nucleoside Phosphorylase, for Patients with Chronic Lymphocytic Leukemia (CLL). Balakrishnan, Kumudha

106 11 p. 2119
artikel
1493 Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Ting, David T.

106 11 p. 3665
artikel
1494 Development of New Small Molecule Bone Marrow Radioprotectors. Niu, Yunyun

106 11 p. 4196
artikel
1495 Development of Novel CD138 Antigen-Specific Peptide Capable of Eliciting Myeloma-Specific Cytotoxic T Lymphocytes Response. Bae, Jooeun

106 11 p. 3465
artikel
1496 Development of Retargeted CD38-Specific NK-92 Cell Line for Potential Anti-Myeloma Immunotherapy. Yang, Shihong

106 11 p. 5104
artikel
1497 Development of Small Molecule Inhibitor of the AML1-ETO Oncoprotein. Grembecka, Jolanta

106 11 p. 1515
artikel
1498 Development of Small Molecule Inhibitors of the CBFβ-SMMHC Oncoprotein. Bushweller, John H.

106 11 p. 3359
artikel
1499 Dexamethasone Dose and Schedule Significantly Influences Remission Rate and Toxicity of Induction Therapy in Adult Acute Lymphoblastic Leukemia (ALL): Results of the GMALL Pilot Trial 06/99. Goekbuget, Nicola

106 11 p. 1832
artikel
1500 Dexamethasone Induces Apoptosis “Ex Vivo” in Chronic Lymphocytic Leukemia Cells with Either Unmutated IgVH Genes or High ZAP-70 Expression. Muntanola, Ana

106 11 p. 2945
artikel
1501 Dexamethasone Promotes Transgene Expression and Supresses the Early Immune /Inflammatory Response in Adenovirus- Mediated Gene Delivery to Hemophilic Mice. Othman, Maha

106 11 p. 5534
artikel
1502 Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial. Labar, Boris

106 11 p. 1834
artikel
1503 Dexmethasone Down-Regulates Stromal Cell-Derived Factor-1 Production in Bone Marrow Stromal Cells: Implications in Myeloma Cell Biology. Kim, Seong-Woo

106 11 p. 2510
artikel
1504 D-4F Restores eNOS-Dependent Vasodilation in Sickle Cell Disease by Decreasing Proinflammatory HDL. Pritchard Jr., Kirkwood A.

106 11 p. 2324
artikel
1505 Diabetes, Hypertension and Cardiovascular Events in Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study. Baker, K. Scott

106 11 p. 699
artikel
1506 Diagnostic Approach to CD5+/CD23+ Leukemic Non-Hodgkin Lymphomas Lacking Lymphnode Histopathology. Giudice, Ilaria Del

106 11 p. 4690
artikel
1507 Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group. Ruutu, Tapani

106 11 p. 400
artikel
1508 Diamond Blackfan Anemia: An RPS19 Transcript Variant Specifically Interacts with Nuclear Proteins. Frojmark, Anne-Sophie

106 11 p. 1032
artikel
1509 Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients with Sickle Cell Disease. Sachdev, Vandana

106 11 p. 206
artikel
1510 Dicentric(7;9)(p11;p11) in Acute Lymphoblastic Leukemia: A Clinical and Laboratory Study of 7 Cases. Pan, Jin-lan

106 11 p. 4333
artikel
1511 Dichotomy of All-Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia. Maeda, Yasuhiro

106 11 p. 4803
artikel
1512 Didox Induced Apoptosis Occurs by Inhibiting DNA Synthesis and Repair Via Down-Regulation of Ribonucleotide Reductase M1 in Multiple Myeloma (MM). Raje, Noopur

106 11 p. 5153
artikel
1513 Dietary Hypercholesterolemia Enhances Heparin-Induced Thrombocytopenia/Thrombosis: A Prothrombotic Risk Factor in a Transgenic Mouse Model. Reilly, Michael P.

106 11 p. 56
artikel
1514 Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL. Jaksic, Branimir

106 11 p. 4981
artikel
1515 Differences in Histone Acetylation Levels in CD34+ Cells between Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Correlation between Higher Levels of Histone 2B Acetylation and Survival in AML. Gorre, M.

106 11 p. 2769
artikel
1516 Differences in Reconstitution of NK-Cell Subsets and Expression of Effector Molecules after HLA-Identical and Haploidentical Allogeneic Stem Cell Transplantation in Patients with AML. Platzbecker, Uwe

106 11 p. 1411
artikel
1517 Different Gene Expression Profiles of CD133+ Cells from Cord Blood and Mobilized Peripheral Blood. Giorgetti, Alessandra

106 11 p. 4210
artikel
1518 Different Histone Deacetylase Inhibitors Affect Distinct Cellular Targets within the Hierarchy of Hematopoietic Stem / Progenitor Cells. Araki, Hiroto

106 11 p. 1721
artikel
1519 Different Histopathological Subtypes of Hodgkin Lymphoma Have Significantly Different Levels of FDG Uptake. Hutchings, Martin

106 11 p. 969
artikel
1520 Differential Activation of Stress Kinases Pathways and Elaboration of Inflammatory Cytokines MCP-1 and RANTES by Major and Minor Group Rhinovirus. Wilson, Megan

106 11 p. 3867
artikel
1521 Differential Antigenic Profile of High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Expressed by 11q23-Positive Acute Leukemia: An Immunotherapeutic Target. Wetzler, Meir

106 11 p. 3261
artikel
1522 Differential Antigenic Targets of Anti-Tumor Immune Response and Selective Immunity to Stem Cell Associated Group B SOX Proteins in Preneoplastic Versus Malignant Gammopathy. Spisek, Radek

106 11 p. 5116
artikel
1523 Differential Changes in Platelet VWF Receptor Following Refrigeration for Short or Long Periods. Josefsson, Emma C.

106 11 p. 3564
artikel
1524 Differential Dose Dependent Effects of Recombinant FVIIa and Enhanced Activity Analogue (NN1731) on Thrombin Generation, Platelet Function and Clot Structure in Blood from Normal Volunteers and Patients with Factor VIII Deficiency with or without Factor VIII Inhibitor Antibodies. Brophy, Donald F.

106 11 p. 4033
artikel
1525 Differential Effects of Extracellular Matrix Proteins on Proplatelet Formation: A Novel Role for Fibrinogen. Larson, Mark K.

106 11 p. 2654
artikel
1526 Differential Effects of HOXB4 Overexpression on Short and Long-Term Repopulating Cells in Nonhuman Primates. Zhang, Xiao-Bing

106 11 p. 33
artikel
1527 Differential Effects of Lovastatin and Allopurinol Therapy in a Murine Model of Sickle Cell Disease. Pritchard Jr., Kirkwood A.

106 11 p. 2325
artikel
1528 Differential Expression of Genes in Multiple Myeloma (MM) and Identification of Candidates to Targeted Therapy. Felix, Roberta S.

106 11 p. 5093
artikel
1529 Differential Expression of Granzymes A and K in Subsets of Human T-Cells and NK-Cells. Zeberg, Lennart

106 11 p. 3917
artikel
1530 Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression. Joshi, Avadhut D.

106 11 p. 2103
artikel
1531 Differential Expression of the Homeobox Gene MIXL1 in Non Hodgkin (NHL) and Hodgkin Lymphomas (HL). Drakos, Elias

106 11 p. 3014
artikel
1532 Differential Expression Profile of the Proteome and Transcriptome in Aggressive and Indolent Chronic Lymphocytic Leukemia. Liu, Yu-Tsueng

106 11 p. 2101
artikel
1533 Differential GATA-1 Sensitivities of Target Loci. Johnson, Kirby D.

106 11 p. 1748
artikel
1534 Differential Gene Expression in CLL Cells from Bone Marrow and Peripheral Blood Suggests a Role of Bone Marrow Stroma in Leukemic Cell Proliferation. Wiestner, Adrian

106 11 p. 708
artikel
1535 Differential Gene Expression Profiles in CD34+ Myelodysplastic Syndrome Marrow Cells. Sridhar, Kunju

106 11 p. 3424
artikel
1536 Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein. Khasawneh, Fadi T.

106 11 p. 3571
artikel
1537 Differential Modulation of the β-Like Globin Genes by KLFs Isolated with a γ-Globin CACCC Bait. Moi, Paolo

106 11 p. 3637
artikel
1538 Differential Patterns of Transcriptional Protein Expression May Explain Functional Differences between Hematopoietic Progenitors Derived from Human ESC's and Fetal Hematopoietic Tissues. Shaaban, Aimen F.

106 11 p. 3615
artikel
1539 Differential Presence of Truncated Forms of Transcription Factor Yin Yang 1 (YY1) in Bone Marrow of Multiple Myeloma Patients. Neshat, Mehran S.

106 11 p. 5083
artikel
1540 Differential Protein Expression of Zinc Finger Proteins and Cell Cycle Regulators between Lipopolysaccharide (LPS)-Activated Cord Blood (CB) and Adult Peripheral Blood (APB) Dendritic Cells (DC) Derived from Monocytes: Implication of CB Versus APB DC Differential Innate and Adaptive Immunity. Jiang, H.

106 11 p. 2209
artikel
1541 Differential Regulation of bFGF- and VEGF-Induced Angiogenesis in Mice Lacking Junctional Adhesion Molecule-A. Naik, Meghna U.

106 11 p. 533
artikel
1542 Differential Requirement for Cell Division in the Development of Terminally Differentiated Neutrophils and Macrophages from Their Common Progenitors. Sugimoto, Yuka

106 11 p. 2218
artikel
1543 Differential Response to Proteosome Inhibition in EBV Positive and Negative Lymphoma Cell Lines: Clinical Implications in Post Transplant Lymphoproliferative Disorders (PTLD). Alsayed, Yazan

106 11 p. 2413
artikel
1544 Differential Role for VLA-5 in Mobilization of Heamotopoieic Stem Cells Toward Peripheral Blood and Homing to Bone Marrow and Spleen. Wierenga, Pieter K.

106 11 p. 2190
artikel
1545 Differentiation Dependent Dynamics of Histone Modifications during Myelopoiesis. Harris, Robert G.

106 11 p. 2716
artikel
1546 Differentiation of Human Embryonic Stem Cells into Mesenchymal Stem Cells. Olivier, Emmanuel N.

106 11 p. 1389
artikel
1547 Differentiation of Human ES Cell into the Hemangioblast. Carrier, Ewa

106 11 p. 4224
artikel
1548 Differentiation of Systematically Injected Mesenchymal Stem Cells into Retina Cells in the Rat Eye. Park, Sung-Kyu

106 11 p. 1688
artikel
1549 Differentiation Profiling of Marrow Stem Cells: A Megakaryopoietic Hotspot and the Continuum Model of Hematopoiesis. Colvin, Gerald A.

106 11 p. 4217
artikel
1550 Differentiation Therapy for Poor Risk Myeloid Malignancies: Results of a Dose Finding Study of Bryostatin-1 (BRYO) + GM-CSF. Smith, B. Douglas

106 11 p. 2792
artikel
1551 Different Patterns of Cytogenetic Evolution in CML Treated with Imatinib. Haase, Detlef

106 11 p. 4496
artikel
1552 Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population. Santos, Moema Nene

106 11 p. 106
artikel
1553 Diffuse B-Large Cell Lymphomas (DBLCL) with Hepatitis-C Virus (HCV) Infection: Clinical Outcome and Preliminary Results of a Pilot Study Combining R-CHOP with Antiviral Therapy. Musto, Pellegrino

106 11 p. 2447
artikel
1554 Directed Donor Cord Blood Transplantation for Hematological Disorders. Walters, Mark C.

106 11 p. 2035
artikel
1555 Direct Evidence for Ex Vivo Expansion of Human Hematopoietic Stem Cells. Ando, Kiyoshi

106 11 p. 798
artikel
1556 Direct Evidence of Multilineage Differentiation and Self-Renewal Division of Individual Human Hematopoietic Stem Cell Clones In Vivo. Yahata, Takashi

106 11 p. 1725
artikel
1557 Direct Injection of Allogeneic Multipotent Adult Progenitor Cells Improves Cardiac Function after Myocardial Infarct. Hof, Wouter van't

106 11 p. 2206
artikel
1558 Disclosure of Copy Number Alterations in AML with Normal Karyotype Using Matrix-Based Comparative Genomic Hybridization. Rucker, Frank G.

106 11 p. 759
artikel
1559 Discordance between the 1st and 2nd Low Molecular Weight Heparin Standards. Implications for Dosing. Jeske, Walter P.

106 11 p. 4158
artikel
1560 Discordant Serum Folate Result Unique to the Beckman Access Assay. Wakeman, Lisa

106 11 p. 3704
artikel
1561 Discovery of Genetic Markers Associated with Clozapine Induced Agranulocytosis. Gerson, Stanton

106 11 p. 3074
artikel
1562 Discrepancies in p21ras, p53, and Mdm2 Protein Expression Predict Worse Prognosis in Acute Myeloid Leukemia. Schulz, Elizabeth

106 11 p. 4521
artikel
1563 Discrepancy between Phenotype and Genotype for Factor V Leiden Mutation in Recipients of Liver Transplant. Ayala, Rosa M.

106 11 p. 4120
artikel
1564 Discrepancy in Detecting Bcr-Abl Kinase Domain Mutations between Cells from Bone Marrow and Cells from Peripheral Blood, and Greater Concordance between Bone Marrow Cells and Plasma Free RNA. Ma, W.

106 11 p. 4849
artikel
1565 Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on Tissue Microarray (TMA) of Diagnostic Lymph Nodes (LN). Goff, Lindsey K.

106 11 p. 603
artikel
1566 Disease Stage Strongly Modulates Responsiveness to Targeted Agents in Nf1 Mutant Mice with Myeloprolfierative Disease (MPD) and Acute Myeloid Leukemia (AML). Lauchle, Jennifer O.

106 11 p. 496
artikel
1567 Disparities in Criteria for Initiating Chelation Therapy for Iron Overload in Patients with Myelodysplastic Syndromes (MDS). Bennett, John M.

106 11 p. 2535
artikel
1568 Dispermic Chimerism in a Blood Donor with Apparent B3 Blood Group and Mosaic 47, XYY Syndrome. Cho, Duck

106 11 p. 1896
artikel
1569 Disruption of Leukemia/Stroma Cell Interactions by CXCR4 Antagonist AMD3465 Enhances Chemotherapy-Induced Apoptosis in AML. Zeng, Zhihong

106 11 p. 474
artikel
1570 Dissecting the Molecular Mechanisms of Mutant C/EBPalpha (p30) in Normal and Malignant Human Hematopoiesis. Cammenga, Jorg

106 11 p. 2995
artikel
1571 Dissection of Submicroscopical Aberrations and Clonal Evolution from Birth To Diagnosis and Relapse in a Childhood AML FLT3-ITD Positive Patient by RQ-PCR and SNP Array Analyses. Cazzaniga, Giovanni

106 11 p. 4337
artikel
1572 Disseminated Intravascular Coagulation Associated with Acute Hemoglobinemia or Hemoglobinuria Following Rho(D) Immune Globulin Intravenous Administration for Immune Thrombocytopenic Purpura. Gaines, Ann R.

106 11 p. 1242
artikel
1573 3′ Distal Regulatory Elements Required for Human CD34 Expression in Transgenic Mice. Levantini, Elena

106 11 p. 125
artikel
1574 Distinct Characteristics of t(8;21) Acute Myeloid Leukemia with Active KIT Mutation. Lorenzo, Felipe

106 11 p. 3297
artikel
1575 Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF. Bruns, Ingmar

106 11 p. 5191
artikel
1576 Distinct Hemostatic Profile of Leukocytes in Essential Thrombocythemia (ET) Carrying the JAK2 V617F Mutation. Falanga, Anna

106 11 p. 378
artikel
1577 Distinctive Patterns of BCL6 Molecular Alterations in Different Subsets of Diffuse Large B-Cell Lymphoma and Their Functional Consequences. Iqbal, J.

106 11 p. 160
artikel
1578 Distinctive Roles of Stem Cell Factor and IL-7 in T Cell Development. Wang, Hongfang

106 11 p. 3156
artikel
1579 Distinct Profile of FLT3 Mutations in Brazil. Souza, Danielle L.C.F.

106 11 p. 4532
artikel
1580 Distinguishing Antiphospholipid Antibodies from an Acquired Factor Inhibitor: A Novel Laboratory Approach. Leuenberger, Kurt P.

106 11 p. 2150
artikel
1581 Distribution and Differentiation of Donor-Derived Bone Marrow Stem Cells in Various Areas of the Human Brain. Wang, Rui-Yu

106 11 p. 1685
artikel
1582 Distribution of CMV Glycoprotein B Genotypes after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single Center Study. Wu, Xiaojin

106 11 p. 5368
artikel
1583 Divergent Roles of Histone Deacetylases in Human Adult Eythropoiesis. Ohishi, Kohshi

106 11 p. 130
artikel
1584 Diving Suit: Sterile, Ambulatory, Personnal Device for Protective and Preventive Isolation of Nosocomial Invasive Fungal Infections (IFI) in Neutropenic Patients Hospitalised in Laminar Air Flow Room Who Need a Disruption of Isolation. Thiebaut, Anne

106 11 p. 5569
artikel
1585 DKK-1 Is a Widely Expressed, Potent Tumor-Associated Antigen in Multiple Myeloma Recognized by Cytotoxic T Lymphocytes. Yi, Qing

106 11 p. 3467
artikel
1586 Dkk1 Transgenic Mice for the Study of Bone Lesions in Human Multiple Myeloma. Fujita, Ken-ichi

106 11 p. 2505
artikel
1587 DLA-Haploidentical Stem Cell Allografts after Anti-CD44 Therapy and Nonmyeloablative Conditioning: The Impact of Donor Lymphocyte Infusion (DLI), Pentostatin and Graft Composition on Donor Chimerism and Rejection. Kerbauy, Fabio

106 11 p. 2194
artikel
1588 DMT1 Mutation in a Patient with Hypochromic Microcytic Anemia: Functional Consequences and Response to Erythropoietin. Priwitzerova, Monika

106 11 p. 3587
artikel
1589 DNA from Potentally Oncogenic Viruses Is Not Detected in Guthrie Cards from Chlidren Who Later Developed Acute Lymphoblastic Leukaemia. Gustafsson, Britt

106 11 p. 4540
artikel
1590 DNA Methylation Changes in Plasma Cell Discrasias. Martin-Acosta, Paloma

106 11 p. 1560
artikel
1591 DNA Microarray Analysis of GPI-Negative Hematopoietic Stem Cells in Paroxysmal Nocturnal Hemoglobinuria Patients. Ikeda, Kazuhiko

106 11 p. 1048
artikel
1592 DNA Repair Gene Expression in CD34+ Bone Marrow Cells in MDS Patients with Mutiple Chromosomal Abnormalities by Array-Based Comparative Genomic Hybridization (A-CGH). Gondek, Lukasz P.

106 11 p. 3423
artikel
1593 DNA Sequence of Hemoglobin Chico. Fond, Aaron M.

106 11 p. 3784
artikel
1594 DNA Topoisomerase II Poisons and the Etiology of Acute Leukemia in Infants. Kolaris, Christos P.

106 11 p. 2850
artikel
1595 DOCK180 Is Induced with Differentiation from CD14 Positive Monocytes and It Regulates Phagocytosis in Both Macrophages and Dendritic Cells. Fujimoto, Katsuya

106 11 p. 3077
artikel
1596 Does Combined Immunochemotherapy with the Monoclonal Antibody Rituximab Improve Overall Survival in the Treatment of Patients with Indolent Non-Hodgkin Lymphoma? Preliminary Results of a Comprehensive Meta-Analysis. Schulz, Holger

106 11 p. 351
artikel
1597 Does Early Lymphocyte Recovery Predict Superior Survival in Children and Young Adults Undergoing Hematopoietic Stem Cell Transplantation?. Imran, Hamayun

106 11 p. 5372
artikel
1598 Does Early Myeloid Recovery Predict Superior Survival in Children and Young Adults Undergoing Hematopoietic Stem Cell Transplantation?. Imran, Hamayun

106 11 p. 5323
artikel
1599 Does High Dose Cytosine Arabinoside Improves Disease Free Survival for Down Syndrome Acute Myelocytic Leukemia Patients?. Saleh, Mahasen

106 11 p. 4612
artikel
1600 Does Highly Active Anti-Retroviral Therapy (HAART) Delay Myeloid Engraftment after Autologous Stem Cell Transplant (ASCT) in HIV Associated Lymphoma (HIV+Ly) Patients?. Diez-Martin, Jose L.

106 11 p. 1766
artikel
1601 Does Increased Body Mass Index Predispose Myeloma Patients to Fractures or Shortened Survival?. Scott, Emma C.

106 11 p. 5051
artikel
1602 Does the Platelet Factor 4 (PF4) ELISA Correlate with the Clinical Diagnosis of Type II Heparin-Induced Thrombocytopenia?. Streiff, Michael B.

106 11 p. 2179
artikel
1603 Does the Use of Different Factor VIII Products Influence Inhibitor Formation in Patients with Haemaphilia A. Howarth, David E.

106 11 p. 4029
artikel
1604 Does Thromboprophylaxis Reduce Mortality in Medical Patients? A Systematic Review and Meta-Analysis of Randomized Cntrolled Tials. Dentali, Francesco

106 11 p. 905
artikel
1605 Dominant and Pharmacologically Sensitized ENU Mutagenesis Screens Uncover Novel Regulators of Hematopoiesis and Model Hematopoietic Disease. Stanford, William L.

106 11 p. 1378
artikel
1606 Dominant Negative Effect of Kinase-Inactive Bcr-Abl on Cell Survival and DNA Damage Response Pathways in Imatinib-Treated Cells. van der Kuip, Heiko

106 11 p. 2887
artikel
1607 Donor CD4+ T and B Cells in Transplants Induce Autoimmune-Like Chronic Graft Versus Host Disease. Zhang, Chunyan

106 11 p. 1313
artikel
1608 Donor DC Subsets Polarize Donor T-Cell Immune Responses in Allogeneic BMT. Li, Jian-Ming

106 11 p. 573
artikel
1609 Donor-Derived Hematopoietic Stem Cells Repair the Bone Marrow Sinusoids Following Bone Marrow Transplant. Slayton, William B.

106 11 p. 1714
artikel
1610 Donor KIR Genotype Does Not Affect VZV Reactivation after Allogeneic Haematopoietic Stem Cell Transplantation. Narayanan, Sujaatha

106 11 p. 3236
artikel
1611 Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation. Kroeger, Nicolaus

106 11 p. 2040
artikel
1612 Donor Lymphocyte Infusions from Unrelated Donors for Treatment of Relapsed Chronic Myelogenous Leukemia: Importance of Initial Cell Dose. Hertenstein, Bernd

106 11 p. 2055
artikel
1613 Donor Lymphocyte Transfusion (DLT) in the Treatment of Relapsed CML after Allogeneic PBSCT - A Retrospective Analysis of 346 Patients by the EBMT Chronic Leukemia Working Party. Schmid, Christoph

106 11 p. 704
artikel
1614 Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning. Baron, Frederic

106 11 p. 398
artikel
1615 Donor Origin of Multipotent Adult Progenitor Cells in Radiation Chimeras. Reyes, Morayma

106 11 p. 1395
artikel
1616 Donor/Recipient Matching for the -174G/C SNP Polymorphism in the IL-6 Gene Promoter Influences the Outcome of Stem Cell Transplantation. Manzano, Cintia

106 11 p. 5330
artikel
1617 Donor-Specific Tolerance Is Induced after Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation and May Persist after Graft Rejection. Yunusov, Murad Y.

106 11 p. 5230
artikel
1618 Do Pediatric Sickle Cell Disease Patients Develop Diastolic Dysfunction?. Zilberman, Mark V.

106 11 p. 3195
artikel
1619 Dose Adjusted EPOCH Chemotherapy Plus Rituximab Combination (DA-R-EPOCH), an Effective Upfront Therapy for Patients with Poor-Risk Aggressive B-Cell Lymphomas. Results of a Pilot Study in a Single Center. López, Andrés

106 11 p. 4716
artikel
1620 Dose Escalated CHOP + Etoposide Followed by Repetitive Autologous Stem Cell Transplantation (MegaCHOEP) with or without Rituximab for Primary Treatment of Aggressive NHL. Glass, Bertram

106 11 p. 1492
artikel
1621 Dose-Escalated Donor Lymphocyte Infusions Post Allogeneic Transplantation in Non-Hodgkin's Lymphoma. Bloor, Adrian J.C.

106 11 p. 2013
artikel
1622 Dose Intensity and Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy. Shayne, Michelle

106 11 p. 3124
artikel
1623 Dose Intensive Induction Chemotherapy Does Not Decrease Tumor Contamination of Autograft or Improve Survival for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant. Sayani, Farzana A.

106 11 p. 2932
artikel
1624 Dose Reduced Conditioning and CD3/CD19 Depletion for Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults: Fast Engraftment and Low Toxicity. Bethge, Wolfgang A.

106 11 p. 5205
artikel
1625 Dose Reduction of Thalidomide in Multiple Myeloma: A Feasible Option without Reducing of Efficacy. Haas, Peter

106 11 p. 5129
artikel
1626 Dosing Patterns and Transfusion Use in Cancer Patients Treated with Erythropoietic Agents: Results of an Observational Study of over 8,000 Patients. Gosselin, Antoine

106 11 p. 3118
artikel
1627 Double Autologous Transplant Versus Tandem Autologus - Non Myeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma. Bruno, B.

106 11 p. 46
artikel
1628 Double Induction Containing Two Courses Versus One Course of High- Dose AraC/ Mitoxantrone (HAM) and Autologous Stem Cell Transplantation Versus Prolonged Maintenance for Acute Myeloid Leukemia (AML). Buchner, Thomas

106 11 p. 272
artikel
1629 Double Unit Cord Blood Transplantation in Children with Acute Leukemia. Yoo, Keon Hee

106 11 p. 2043
artikel
1630 Doubling Time of Soluble CD23 Is an Additional Prognostic Factor in ZAP 70 Positive CLL Patients. Meuleman, Nathalie

106 11 p. 5020
artikel
1631 Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement. Haran, Michal Z.

106 11 p. 4669
artikel
1632 Downregulation of Bub1 and a Defective Spindle Checkpoint in Acute Myeloid Leukemia. Waesch, Ralph

106 11 p. 2846
artikel
1633 Down-Regulation of Cellular Vascular Endothelial Growth Factor (VEGF) Levels Induces Differentiation of Leukemic Cells into Leukemic-Dendritic Cells in Patients with Acute Myeloid Leukemia. Kang, Hyun-Kyu

106 11 p. 2226
artikel
1634 Down Regulation of hTERT Is an Important Mechanism in Apoptosis of MUTZ-l Cells Induced by As2O3. Jin, Jie

106 11 p. 4910
artikel
1635 Downregulation of Interleukin-13 by PUVA Treatment in a Human Model of Graft-Versus-Host Disease May Highlight the Importance of This Cytokine in the Mechanism of Extracorporeal Phototherapy Treatment. Marshall, Scott R.

106 11 p. 5234
artikel
1636 Downregulation of P-Selectin from Activated Platelets Involves Both Receptor Internalization and Shedding upon Binding to PSGL-1. Dole, Vandana S.

106 11 p. 2656
artikel
1637 Downregulation of PU.1 Is Required for Subtype of Multiple Myeloma. Tatetsu, Hiro

106 11 p. 3401
artikel
1638 Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) Results in a High Response Rate in Patients with Refractory Multiple Myeloma (RMM). Baz, Rachid

106 11 p. 2559
artikel
1639 Doxil, Vincritine, Reduced Frequency Dexamethasone in Combination with Thalidomide (DVd-T) Is Associated with Higher Overall and Progression Free Survival as Compared to DVd in Patients with Multiple Myeloma (MM). Almhanna, Khaldoun

106 11 p. 2557
artikel
1640 Dramatic and Sustained Hematologic Complete Remission with Denileukin Diftitox (ONTAK®) in a Patient with Refractory Adult T-Cell Leukemia (ATL). Ziegler, Sheryl L.

106 11 p. 4638
artikel
1641 Dronabinol or Ondansetron Alone and Combined for Delayed Chemotherapy-Induced Nausea and Vomiting (CINV). Jhangiani, Haresh

106 11 p. 5555
artikel
1642 Drotrecogin Alfa (Xigris) Induced Coagulopathy as Measured by Routine Lab Tests in a Community Hospital Setting. Maini, Archana

106 11 p. 4129
artikel
1643 Drug-Dependent Murine Monoclonal Antibodies (mAbs) Mimic Antibodies Found in Patients with Drug-Induced Immune Thrombocytopenia (TP). Bougie, Daniel W.

106 11 p. 731
artikel
1644 Drug-Induced Cutaneous Vasculitis in Patients with Non-Hodgkin's Lymphoma Receiving Bortezomib: A Possible Surrogate Marker of Response. Gerecitano, John

106 11 p. 3334
artikel
1645 Drug Metabolism and Disposition Genes in Israeli HIV Patients: MDR1 and CYP3A4 Polymorphisms May Affect Susceptibility to HIV but Not the Course of the Disease. Kedmi, Meirav

106 11 p. 1434
artikel
1646 dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo. Schmidt, Manuel

106 11 p. 5527
artikel
1647 Dual Inhibition of Blood Coagulation Factors Xa and Iia Synergize To Reduce Thrombus Weight and Thrombin Generation in a Rabbit Arteriovenous Shunt Model of Thrombosis. McClanahan, Thomas B.

106 11 p. 1866
artikel
1648 Dual Role of Soluble Urokinase Plasminogen Activator Receptor Released by the Paroxysmal Nocturnal Hemoglobinuria Cell in Stimulation of Proliferation and Inhibitor of Apoptosis of PNH Cells but Suppression of Normal Phenotype Cell Growth. Sloand, Elaine M.

106 11 p. 1045
artikel
1649 Dual Roles of T/NK Immunomodulatory and Anti-Tumor Properties for Selected Herbal Medicines in Multiple Myeloma Therapy. Fan, Kei

106 11 p. 5097
artikel
1650 Duffy Antigen/Receptor for Chemokines (DARC): Is There a Role in Prostate Cancer?. Anyona, Samuel B.

106 11 p. 4394
artikel
1651 Durable Engraftment of Purified Allogeneic Hematopoietic Stem Cells Following Non-Myeloablative Conditioning. Muchmore, Mary-Elizabeth A.

106 11 p. 2204
artikel
1652 Durable Molecular Remission in Two Acute Promyelocytic Leukemia (APL) Patients Treated with Arsenic Trioxide at First Molecular Relapse. Douer, Dan

106 11 p. 1847
artikel
1653 Durable Remission of Acute Panmyelosis with Myelofibrosis Following Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation. Park, Moo-Rim

106 11 p. 5305
artikel
1654 Durable Remissions with Single Agent As2O3 in the Treatment of Newly Diagnosed Cases of Acute Promyelocytic Leukemia: Risk Stratification within This Group and Potential Impact on Future Algorithms. Mathews, Vikram

106 11 p. 892
artikel
1655 Durable Remission with Decreased HTLV-I Proviral Load after Reduced-Intensity Stem Cell Transplantation (RIST) in Patients with Adult T-Cell Leukemia/Lymphoma (ATL). Tanosaki, Ryuji

106 11 p. 3347
artikel
1656 Duration to Engraftment Requires Significantly Much More Time in Myelodysplastic Syndrome (MDS) Patients as Compared to Acute Myeloid Leukemia (AML) Patients Following Allogeneic Stem Cell Transplantation. Bitan, Menachem

106 11 p. 5326
artikel
1657 Dynamic Alterations in the Expression of P2Y12 Receptor but Not COX-1 in Platelets from Streptozocin-Induced Diabetic Rats. Chen, Chi

106 11 p. 2638
artikel
1658 Dynamic Regulation of Src by Csk in Integrin α IIb β 3 Mediated Signalling. Vielreicher, Martin

106 11 p. 2661
artikel
1659 Dynamics of Calcium Mobilization in Platelets during Thrombus Formation in a Living Mouse. Dubois, Christophe

106 11 p. 649
artikel
1660 Dyrk-3 Kinase Is an Erythroid Cell-Intrinsic Attenuator of Stress Erythropoiesis. Bogacheva, Olga

106 11 p. 566
artikel
1661 Dysfunctional T Regulatory Cells in Myeloma: Molecular Mechanisms of Dysregulation. Prabhala, Rao H.

106 11 p. 3462
artikel
1662 Dysregulated Arginine Metabolism and Elevated Arginase Activity in Thalassemia. Morris, Claudia R.

106 11 p. 3644
artikel
1663 Dysregulated Expression of Myeloid Nuclear Differentiation Antigen (MNDA) in MDS: Possible Role in TRAIL-Induced Apoptosis. Briggs, Robert C.

106 11 p. 4933
artikel
1664 Earlier Administration of Rituximab Allows Higher Rate of Long-Lasting Response in Adult Patients with Autoimmune Thrombocytopenia. Zaja, Francesco F.

106 11 p. 3991
artikel
1665 Early and Sustained Response to Azacytidine in High-Risk MDS Patients with Monosomy 7 Correlates with Increased Apoptosis and Not CDKN2B Demethylation. Raj, Kavita K.

106 11 p. 2530
artikel
1666 Early Bortezomib Following Allogeneic Stem Cell Transplantation (SCT) for Multiple Myeloma To Enhance or Maintain Remission Status. Kroeger, Nicolaus

106 11 p. 2010
artikel
1667 Early Detection of Imminent Hematologic Relapse Due to BCR-ABL Kinase Domain Mutations in CML Patients on Imatinib Therapy by D-HPLC. Ernst, Thomas

106 11 p. 1088
artikel
1668 Early Indicators of the Dysmetabolic Syndrome in Young Survivors of Acute Lymphoblastic Leukemia in Childhood. Moschovi, Maria

106 11 p. 4543
artikel
1669 Early Intervention in Minimal Residual Disease after Allogeneic Transplant for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Prolonged Survival by Imatinib. Miyamura, Koichi

106 11 p. 4581
artikel
1670 Early Lymphocyte Recovery after Autologous Stem Cell Transplantation Predicts Superior Survival in Mantle Cell Lymphoma. Joao, Cristina

106 11 p. 5466
artikel
1671 Early Lymphocyte Recovery Predicts Superior Survival after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in Patients with Multiple Myeloma. Hiwase, Devendra K.

106 11 p. 5487
artikel
1672 Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy. Cho, Robert

106 11 p. 867
artikel
1673 Early “Mini” Donor Lymphocyte Infusions after Reduced-Intensity Conditioning in Allogeneic Transplant of Highly Purified CD34+ Cells from HLA-Identical Donors in Pediatric Leukemia Patients. Diaz, Miguel A.

106 11 p. 5387
artikel
1674 Early Mortality of Newly Diagnosed Adult Acute Promyelocytic Leukemia Treated with the AIDA Protocol. Gortzolidis, George

106 11 p. 4617
artikel
1675 Early Predictors of Fetal Hemoglobin Response to Hydroxyurea in Sickle Cell Disease. Partovi, Kristine

106 11 p. 2344
artikel
1676 Early Response Evaluation with 18FDG-PET Scanning, but Not Phenotypic Profile, Are Predictive of Outcome in Diffuse Large B-Cell Lymphoma. Dupuis, Jehan

106 11 p. 1914
artikel
1677 Early Results from LRF CLL4: A UK Multicenter Randomized Trial. Catovsky, Daniel

106 11 p. 716
artikel
1678 Early Results of the Clinical Collection and Genetic Correction of Fanconi Complement Type A Hematopoietic Stem Cells. Kelly, Patrick

106 11 p. 1283
artikel
1679 Early Safety and Efficacy Analysis of a Phase II Study of Sequential R-CHOP and Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) for Elderly High Risk Patients with Untreated DLBCL. Hamlin, Paul A.

106 11 p. 926
artikel
1680 Early Serum Free Light Chain Responses Following High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis Predict Treatment Outcomes. Sanchorawala, Vaishali

106 11 p. 1160
artikel
1681 Early Treatment with CD4+CD25+ Regulatory T Cells Provides Prolonged Suppressive Effects Which Control Evolving but Not Established Graft-Versus-Host-Disease. Nguyen, Vu H.

106 11 p. 1303
artikel
1682 4E-Binding Protein 1 (4E-BP1) in CD34+ Cells as Measured by Quantitative Flow Cytometry Is an Independent Prognostic Factor in Patients with Acute Myeloid Leukemia. Gorre, M.

106 11 p. 2772
artikel
1683 Echocardiography Identifies Changes in Left Ventricular Cardiac Function after Low Doses of Anthracycline, Particularly in Older Patients. Kruger, Anton R.

106 11 p. 4722
artikel
1684 Economical Analysis of Implementation of External Quality Controls in a General Hospital Hematology Laboratory. Recasens, Valle

106 11 p. 5590
artikel
1685 Economy Class Syndrome: A “Pilot” Study. Kristinsson, Sigurdur Y.

106 11 p. 4130
artikel
1686 EDAS Procedure for Sickle Cell Anemia with Stroke: Report of Four Cases. Aygun, Banu

106 11 p. 3803
artikel
1687 Effective Asparagine Depletion with Pegylated Asparaginase Results in Improved Outcomes in Adult Acute Lymphoblastic Leukemia (ALL) — Cancer and Leukemia Group B Study 9511. Wetzler, Meir

106 11 p. 1825
artikel
1688 Effective CD34+ Stem Cell Mobilization with Low-Dose Pegfilgrastim. Gladstone, Douglas E.

106 11 p. 5507
artikel
1689 Effective Depletion of Alloreactive T Cells by CD95l-Transduced Cells with Preservation of FoxP3 Regulatory T-Cells. Jacobsen, Eva-Maria

106 11 p. 1258
artikel
1690 Effective Ex Vivo-Generation and Quantification of Leukemia-Derived DC Has To Precede a Specific T-Cell Stimulation for Adoptive Immunotherapy in AML and MDS. Schmetzer, Helga Maria

106 11 p. 5241
artikel
1691 Effectiveness of Darbepoetin alfa Administered Every 3 Weeks on Clinical Outcomes in Patients with Hematologic Malignancies and Chemotherapy-Induced Anemia. Boccia, Ralph Vincent

106 11 p. 3767
artikel
1692 Effective Targeting of MEK/ERK Signalling at Nanomolar Concentrations by the Novel Small Molecule Inhibitor PD0325901 in Hematopoietic and Solid Tumors. Ricciardi, Maria R.

106 11 p. 3370
artikel
1693 Effective Treatment of Basophilic Leukemia of the Central Nervous System in a CML Patient with the Combination of Imatinib Mesylate and Valproic Acid. Nahajevszky, Sarolta

106 11 p. 4886
artikel
1694 Effective Treatment of Resistant Hematological Malignancies by IL-2 Activated NK Cells Using Haploidentically Mismatched Donors by Induction of Graft-Versus-Tumor (GVT) Effect While Avoiding GVHD. Slavin, Shimon

106 11 p. 5400
artikel
1695 Effective Treatment with Imatinib Mesylate and Donor Lymphocyte Infusion Following Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia. Li, Jianyong

106 11 p. 5419
artikel
1696 Effect of Adding Rituximab (R) to Induction Treatment and High Dose Chemotherapy (HDC) Prior to Autologous Stem Cell Transplantation (ASCT) as First Line Therapy in Stage III-IV Diffuse Large B-Cell Lymphoma (B-DLCL) at Poor Prognosis. Vitolo, Umberto

106 11 p. 676
artikel
1697 Effect of AMD3100 on T Lymphocyte Subpopulations in Apheresis Products of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Non Hodgkin Lymphoma. Holtan, Shernan G.

106 11 p. 2918
artikel
1698 Effect of Arsenic Trioxide on E14 Murine Embryonic Stem Cells In Vitro. Graham-Evans, Barbara

106 11 p. 4409
artikel
1699 Effect of Bax G125A Single Nucleotide Polymorphism (SNP) on Bax Gene Expression in Diffuse Large Cell Lymphoma. Saxena, Anurag

106 11 p. 4379
artikel
1700 Effect of DMT1 Mutations at Birth and in the First Years of Life. Achille, Iolascon

106 11 p. 3586
artikel
1701 Effect of Dose Reductions on Response to 500-μg Darbepoetin alfa Administered Once Every 3 Weeks for the Treatment of Chemotherapy-Induced Anemia: Analysis from a Randomized, Double-Blind, Active-Controlled Trial. Canon, Jean-Luc

106 11 p. 3558
artikel
1702 Effect of Enzyme Replacement Therapy on Bone Mineral Density in Type 1 Gaucher Disease. Wenstrup, Richard

106 11 p. 3895
artikel
1703 Effect of Erythropoietin on Platelet Function and Glycoprotein Expression in Patients with MDS. Girtovitis, Fotis F.I.

106 11 p. 3993
artikel
1704 Effect of Homoharringtonine on Differentiation and Apoptosis of Human Leukemic Cell. Mai, Wenyuan

106 11 p. 4425
artikel
1705 Effect of INS50589, a Reversible ADP-Receptor Antagonist, on Platelet Function and Blood Loss in a Canine Model of Cardiopulmonary Bypass. Bode, Arthur P.

106 11 p. 2172
artikel
1706 Effect of Intravenous Busulfan Versus Total Body Irradiation on Donor Chimerism and Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (AlloSCT) in Mice. Wang, Jie

106 11 p. 5254
artikel
1707 Effect of Iron Intake on Control of Body Iron in Patients with Thalassemia Major Treated with Deferasirox (Exjade®, ICL670). Cohen, A.

106 11 p. 822
artikel
1708 Effect of Plasma Exchange on Acute Graft Versus Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Cai, Zhen

106 11 p. 5246
artikel
1709 Effect of Post-Thaw Washing Prior to Transplantation of Umbilical Cord Blood Units (UCB) That Were Depleted of Plasma but Not of Red Blood Cells. Chow, Robert

106 11 p. 5283
artikel
1710 Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group. Thomas, Xavier

106 11 p. 1862
artikel
1711 Effect of p53 Silencing on Asenic Tioxide-Induced Apoptotic Pathways in a Myeloma Cell Line Expressing w.t.p53. Fatih, Kircelli

106 11 p. 4387
artikel
1712 Effect of Recombinant Activated Factor VII (rFVIIa) on Platelet and Clotting Systems in Healthy Volunteers. Gabriel, Don A.

106 11 p. 4053
artikel
1713 Effect of Storage Time and Temperature on Fresh Unprocessed Cord Blood. Vowels, Marcus R.

106 11 p. 5272
artikel
1714 Effect of Treatment with Rituximab in Patients with Refractory Autoimmune Cytopenias. Dungarwalla, Moez

106 11 p. 2405
artikel
1715 Effect of Zoledronic Acid on Bone Mineral Density in Thalassemia-Induced Osteoporosis: Results of a Phase II Clinical Trial. Taher, Ali

106 11 p. 3826
artikel
1716 Effect on NB4 Cells Proliferation, Differentiation and Resistance to Chemotherapy Apoptosis by VEGF-C cDNA Transfection. Ding, Kaiyang

106 11 p. 1529
artikel
1717 Effects of a Leukemia-Associated Gain-of-Function Mutation of SHP-2 Phosphatase on IL-3 Signaling. Yu, Wen-Mei

106 11 p. 2285
artikel
1718 Effects of Amifostine and Fengling Polysaccharide on Proliferation and Chemoprotection of Human Granulocyte-Macrophage Progenitor Cells. Chen, Bao-An

106 11 p. 4190
artikel
1719 Effects of AMN107, a Novel Aminopyrimidine Tyrosine Kinase Inhibitor, on Human Mast Cells Bearing Wild-Type or Mutated Codon 816 c-kit. Verstovsek, Srdan

106 11 p. 3528
artikel
1720 Effects of 5-Androstenediol on Survival, Clonogenicity, and Expression of IL-6 and NFKB in Irradiated Human Osteoblast and Hematopoietic CD34+ Cells. Xiao, Mang

106 11 p. 4269
artikel
1721 Effects of Apoptosis in Human Activated Peripheral T-Lymphocytes by Immunosuppressive Drugs. Zhu, Xiaoli

106 11 p. 5219
artikel
1722 Effects of Dose Adjustment Rules on Safety during Erythropoietic Therapy: A Retrospective Analysis of Darbepoetin alfa Administered Either Every 3 Weeks or Weekly. Hedenus, Michael

106 11 p. 3376
artikel
1723 Effects of Elevated BCR/ABL Expression Level on Cellular Transformation and Sensitivity to Imatinib in Primitive Human Hematopoietic Cells. Modi, Hardik

106 11 p. 1998
artikel
1724 Effects of Gossypol Acetate on Proliferation and Apoptosis in Lymphoblastoid Cell Line and Primary ALL and CLL Cells. Zhao, Yongqiang

106 11 p. 4405
artikel
1725 Effects of HLA-C and HLA-DQB1 Mismatching on Outcome of Unrelated Donor Marrow Transplantation for Patients with Severe Aplastic Anemia. Kojima, Seiji

106 11 p. 563
artikel
1726 Effects of Human Myeloma Cells on WNT Signaling System in Human Bone Marrow Osteoprogenitor Cells. Giuliani, Nicola

106 11 p. 2503
artikel
1727 Effects of Immunosuppressive Drugs on Hematopoietic Engraftment after Simultaneous Infusion of Apoptotic Cells and Bone Marrow Cells. Masson, Emeline

106 11 p. 5207
artikel
1728 Effects of Mitochondrial Ferritin Expression on Tumor Iron Metabolism and Tumor Growth in Nude Mice Xenografts. Nie, Guangjun

106 11 p. 3582
artikel
1729 Effects of Mycotoxins on Mononuclear Cells (MNCs) in Normal Blood, T-Cell Leukemia and Lymphoma Cell Lines. Klein, Klara R.

106 11 p. 4828
artikel
1730 Effects of Photopheresis on Mononuclear Cells from Healthy Individuals. Kumlien, Gunilla

106 11 p. 1903
artikel
1731 Effects of Single-Dose BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor - in Subjects with Extreme Body Weight. Kubitza, Dagmar

106 11 p. 1872
artikel
1732 Effects of STI571 on the Development of Dendritic Cells Derived from Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia. Jin, Jie

106 11 p. 4874
artikel
1733 Effects of STI571 on the Expression of c-kit Receptor in Mononuclear Cells from the Bone Marrow of Patients with Acute Non-Lymphocytic Leukemia. Feng, Ru

106 11 p. 4451
artikel
1734 Effects of the DNA Methylase Inhibitor Zebularine on Global Gene Expression in AML1-ETO-Positive Acute Myeloid Leukemia. Flotho, Christian

106 11 p. 2998
artikel
1735 Effects of Zotarolimus (ABT-578), Sirolimus, Paclitaxel and Dexamethasone on Cytokine Production by Human Monocytes In Vitro. Li, Lanlan

106 11 p. 3866
artikel
1736 Efficacy and Safety of a New Intravenous Immunoglobulin in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura. Leibl, Heinz

106 11 p. 3984
artikel
1737 Efficacy and Safety of a Single-Course of Yttrium-90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed or Refractory Mantle Cell Lymphoma (MCL) After/Not Appropriate for Autologous Stem Cell Transplantation (ASCT) - A Phase II Trial of the European MCL Network. Weigert, Oliver

106 11 p. 4786
artikel
1738 Efficacy and Safety of Epoetin beta 30 000 IU Once Weekly in Anemic Patients with Non-Myeloid Malignancies Receiving Chemotherapy. Damaj, Gandhi

106 11 p. 4281
artikel
1739 Efficacy and Safety of Fludarabine Combined with Cytarabine in the Treatment of Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL). Jiang, Bin

106 11 p. 4593
artikel
1740 Efficacy and Safety of Posaconazole (POS) in the Treatment of Refractory Invasive Fungal Infections (rIFIs) in Patients with Underlying Renal Impairment. Langston, Amelia A.

106 11 p. 5380
artikel
1741 Efficacy and Safety of the Combination of Genasense™ (Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia. Mavromatis, Blanche

106 11 p. 2129
artikel
1742 Efficacy and Safety of Using G-CSF on Day before Stem Cell Infusion (Day -1) in Hematopoietic Stem Cell Transplantation (HSCT) -A Single Institution Experience from India. Sastry, P.S.R.K.

106 11 p. 5314
artikel
1743 Efficacy and Tolerability of Intravenous Ferric Sodium Gluconate in the Treatment of Iron Deficiency Anemia in Non-Kidney Disease Patients. Miller, Heather J.

106 11 p. 1683
artikel
1744 Efficacy of Alpha-Lipoic Acid in Iron-Induced Oxidative Stress. Lal, Ashutosh

106 11 p. 3599
artikel
1745 Efficacy of Alphanate® (Human Factor VIII/Von Willebrand Factor Concentrate) in Preventing Excessive Bleeding during Surgery or Invasive Procedures in Patients with Congenital Von Willebrand Disease. A Multicenter Retrospective Study. Eyster, M. Elaine

106 11 p. 3951
artikel
1746 Efficacy of Caspofungin as Secondary Prophylaxis in Patients Undergoing Stem Cell Transplantation with Prior Pulmonary and/or Systemic Fungal Infection. de Fabritiis, Paolo

106 11 p. 3225
artikel
1747 Efficacy of Chemotherapy Regimen Containing Pirarubicin on 111 Patients with High-Risk, Relapse and Refractory Acute Leukemia. Huang, Fen

106 11 p. 4607
artikel
1748 Efficacy of Dasatinib in Patients with Chronic Phase Philadelphia Chromosome-Positive CML Resistant or Intolerant to Imatinib: First Results of the CA180013 ‘START-C' Phase II Study. Hochhaus, Andreas

106 11 p. 41
artikel
1749 Efficacy of Diverse High-Dose Regimens Followed by Autologous Peripheral Blood Stem Cell Transplantation in Consecutive Multiple Myeloma Patients: A Single Center Analysis over a 12 Year Period. Haas, Peter

106 11 p. 5478
artikel
1750 Efficacy of Fludarabine and Cytarabine Combination for Salvage Treatment of Refractory/Relapsed Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): Promising Results from a Single Center Experience. Tassara, M.

106 11 p. 4622
artikel
1751 Efficacy of Growth Factors Compared to Chemotherapy in Low-Risk Myelodysplastic Syndromes. Golshayan, A.

106 11 p. 2540
artikel
1752 Efficacy of High-Dose Therapy and Autologous Stem Cell Transplantation for Chemoresistant Hodgkin's Lymphoma. Metcalfe, Tracee L.

106 11 p. 2081
artikel
1753 Efficacy of Low-Dose Recombinant Activated Factor VII (rFVIIa) in Massively Transfused Trauma Patients with Coagulopathy. Quillen, Karen

106 11 p. 950
artikel
1754 Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease. Kerbauy, F.

106 11 p. 792
artikel
1755 Efficacy of Performing a Second Non-Myeloablative Allogenic Stem Cell Transplant. Byrne, Brian J.

106 11 p. 3664
artikel
1756 Efficacy of Prophylactic Anticoagulation To Prevent Thalidomide-Related Deep Venous Thrombosis. Ikhlaque, Nadeem

106 11 p. 5132
artikel
1757 Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis. Wechalekar, Ashutosh D.

106 11 p. 3496
artikel
1758 Efficacy of Single-Agent Bortezomib Versus Thalidomide in Patients with Relapsed or Refractory Multiple Myeloma: A Systematic Review. Prince, Miles

106 11 p. 5160
artikel
1759 Efficacy of Soluble TNFα Inhibitor (Etanercept) for Treatment of Steroid Refractory Acute Graft Versus Host Disease (GVHD) Post Allogeneic Stem Cell Transplantation (SCT). Kennedy, Glen A.

106 11 p. 1806
artikel
1760 Efficacy of the Direct Thrombin Inhibitor Ximelagatran in Maintaining Small-Diameter Vascular Graft Patency. Schmidt, Steven P.

106 11 p. 1871
artikel
1761 Efficacy of Zymogen Factor VII Is Comparable to Activated Factor VII for Nonviral Gene Therapy Treatment of Hemophilia A. Chen, Steven C.

106 11 p. 5543
artikel
1762 Efficient Barrier Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells. Feistritzer, Clemens

106 11 p. 28
artikel
1763 Efficient Thrombin Generation Requires Molecular Phosphatidylserine, Not a Membrane Surface. Majumder, Rinku

106 11 p. 1022
artikel
1764 Efficient Transduction of Common Marmoset (Callithrix jacchus) Hematopoietic and Embryonic Stem Cells Using Foamyvirus Vectors. Horn, Peter A.

106 11 p. 5530
artikel
1765 Efficient Vaccination of Follicular Lymphoma (FL) Patients with Multiple Intradermal (ID) and Intravenous (IV) Administrations of Mature Dendritic Cells (DC) Loaded with Tumor Cell Lysate Ex Vivo. Rossi, Jean-Francois

106 11 p. 1494
artikel
1766 E2f-2 Regulates Caspase-3 Expression and Mitotic Checkpoint Control during End-Stage Erythroid Maturation. Dirlam, Alexandra

106 11 p. 307
artikel
1767 EGFP Is a Useful Long-Term Expression Tracer for Hematopoietic Stem Cells While DsRed Fluorescent Protein Is Not. Tao, Wen

106 11 p. 3057
artikel
1768 Egr1, a Candidate Gene within the Commonly Deleted Segment of Chromosome 5, Plays a Role in Murine Erythropoiesis and Leukemogenesis. Joslin, John M.

106 11 p. 663
artikel
1769 Ehrlichiosis Mimicking T-Cell Lymphoma/Leukemia. Malani, Ashok

106 11 p. 4343
artikel
1770 Elastic Plasma-Protein-Film Blended with Platelet-Releasate Accelerates Healing of Diabetic Mouse Skin Wounds. Tanaka, Ryuhei

106 11 p. 1895
artikel
1771 Elderly Acute Myeloid Leukemia: A Retrospective Analysis of 89 Cases in China. Lu, Zesheng

106 11 p. 4621
artikel
1772 Electron Paramagnetic Resonance Study of Cell-Free Hemoglobin in Sickle Cell Disease: Potential Antioxidant Role of Haptoglobin. Piknova, Barbora

106 11 p. 2345
artikel
1773 Elevated Expression of C/EBPα/ε and c-myb Is Required for Myeloid Differentiation in CML. Kobayashi, Shinichi

106 11 p. 4877
artikel
1774 Elevated Hemoglobin F in an African American Girl with HbS/β Thalassemia: Unraveling the Mechanism. Fond, Aaron M.

106 11 p. 3832
artikel
1775 Elevated Levels of Cell-Derived Microparticles with Procoagulant Activity in Cocaine Abusers: Association with Increased Thrombin Generation and a Prothrombotic State. Pereira, Jaime

106 11 p. 2629
artikel
1776 Elevated Levels of Homocysteine Compromise Blood-Brain Barrier Integrity in Mice. Chauhan, Anil K.

106 11 p. 3856
artikel
1777 Elevated Methylmalonic Acid (MMA) and Homocysteine (Hcys) Levels in Patients with Normal Serum Cobalamin (Cbl) Values: Diabetes Mellitus (DM) and Age as a Possible Causes of Cbl Resistance. Solomon, Lawrence R.

106 11 p. 2254
artikel
1778 Elevated Peripheral Blood (PB) Cytomegalovirus (CMV) Viral Loads and Reduced CD8+ T-Cell Counts Are Common Findings in T-Cell Lymphoma before Initiation of Therapy. Terrence, Grady

106 11 p. 2822
artikel
1779 Elevated Plasma Arginase Levels in Hemoglobinopathies. Larkin, Sandra K.

106 11 p. 2346
artikel
1780 Elevation of Kinase Interacting with Stathmin (KIS) and Promotion of Cellcycle Progression by KIS in Leukemia Cells. Nakamura, Satoki

106 11 p. 1365
artikel
1781 Embryonic to Fetal Globin Switch Is Associated with Erythroid Cell Maturation in Primitive Hematopoiesis Derived from hESCs. Qiu, Caihong

106 11 p. 3625
artikel
1782 Emerging Marrow Fibrosis Is an Early Indicator of Imatinib Failure and Shortened Survival Time in CML Independent of Hematologic, Cytogenetic and Molecular Response. Buesche, Guntram

106 11 p. 1106
artikel
1783 Emp Null Mice Are Non-Viable and Exhibit Erythroid Differentiation Defect. Soni, Shivani

106 11 p. 806
artikel
1784 Endogenous Cannabinoid-Like Arachidonoyl Serine Induces Angiogenesis through Novel Pathways. Zhang, Xuefeng

106 11 p. 3690
artikel
1785 Endogenous Platelet PF4 Promotes In Vivo Activated Protein C (APC) Generation and Survival after Lethal Lipopolysaccharide Challenge in Mice: A Potential Physiologic Role for PF4. Kowalska, M. Anna

106 11 p. 27
artikel
1786 Endogenous Thrombin Potential (ETP) for Assessing the Risk of Recurrent Venous Thromboembolism. Eichinger, Sabine

106 11 p. 1622
artikel
1787 Endogenous TNFα Mediates Cell Survival and Chemotherapy Resistance by Activating the PI3K/Akt Pathway in Childhood Acute Lymphoblastic Leukemia. Gu, Lubing

106 11 p. 4551
artikel
1788 Endothelial Function in Patients with Essential Thrombocytosis. Koren-Michowitz, Maya

106 11 p. 3983
artikel
1789 Endothelial Microparticles (EMP) Inhibit ADAMTS13 Activity: Implications in Thrombotic Thrombocytopenic Purpura. Jimenez, Joaquin J.

106 11 p. 3676
artikel
1790 Endothelial Microparticles, Platelet and Leukocyte Activation and Cellular Interactions in Patients with Non-Valvular Atrial Fibrillation. Chirinos, Julio A.

106 11 p. 2633
artikel
1791 Endothelial Progenitor Cells (EPC) with Colony Forming Capacity Are Derived from the Monocytic-Macrophage Lineage. Lopez-Holgado, Natalia

106 11 p. 4228
artikel
1792 Enforced STAT3 and PU.1 Expression Activates Type I Interferon-Producing Cell and Dendritic Cell Differentiation Programs in Megakaryocyte/Erythrocyte Progenitors. Onai, Nobuyuki

106 11 p. 201
artikel
1793 Engaging the NKG2D Receptor with a Novel Bispecific Protein (ULBP2-antiCD138) Activates NK Cells and Has Potent Antitumor Activity Against Human Multiple Myeloma. von Strandmann, Elke Pogge

106 11 p. 5157
artikel
1794 Enhanced Anti-Myeloma Activity by Combination of Receptor Tyrosine Kinase (RTK) Inhibition, Proteasome Inhibition, and Dexamethasone: Therapeutic Implications for t(4;14) and t(14;16) Multiple Myeloma (MM) Subgroups. Bisping, Guido

106 11 p. 112
artikel
1795 Enhanced Apoptosis and Reduced Angiogenesis in DLBCL. Vadasz, Zahava

106 11 p. 4681
artikel
1796 Enhanced Apoptosis in Response to Chemotherapeutic Agents in Leukemic Cells Is Associated with Post-Transcriptional Modification of Cyclin A1. Ekberg, Jenny

106 11 p. 4292
artikel
1797 Enhanced Engraftment and Maintenance of CXCR4 Expressing CD34+ Cells In Vivo Is Related to Microenvironmental Interactions, Rather Than Direct Receptor Signaling to Hematopoietic Stem Cells. Anderson, Naomi J.

106 11 p. 2306
artikel
1798 Enhanced Erythroid Differentiation of Murine Embryoid Bodies That Are Exposed to Short-Chain Fatty Acids during Development. Hallock, Jennifer L.

106 11 p. 3646
artikel
1799 Enhanced Expression of Two Novel GTP-Independent Alternatively Spliced Forms of Tissue Transglutaminase in Human Platelets and Leukocytes. Lai, Thung-S.

106 11 p. 2236
artikel
1800 Enhanced Fibrin Clot Formation and Stability with a Superactive Analog of Factor VIIa in an In Vitro Model of Hemophilia. Wolberg, Alisa S.

106 11 p. 4056
artikel
1801 Enhanced HDAC (Histone Deacetylase) Enzyme Activities in Blood CD 34+ Cells in Patients with Agnogenic Myeloid Metaplasia Are Not Related to Jak 2 Mutation. Wang, Jen-Chin

106 11 p. 4953
artikel
1802 Enhanced Immune Reconstitution and Function by CD4+CD25+ Regulatory T Cells Following Allogeneic Hematopoietic Cell Transplantation. Nguyen, Vu H.

106 11 p. 64
artikel
1803 Enhanced In Vivo Homing of Uncultured and Selectively Amplified Umbilical Cord Blood CD34+ Cells by Co-Transplantation with Cord Blood Derived Unrestricted Somatic Stem Cells. Chan, Shing Leng

106 11 p. 1276
artikel
1804 Enhanced Levels of Apoptosis by Combination of Farnesyl Transferase Inhibition (Tipifarnib) and Proteasome Inhibition (Bortezomib) in Myeloma Cell Lines and Primary Myeloma Cells and Its Mechanistic Effects on Akt and Caspase Pathways. Kaufman, Jonathan L.

106 11 p. 1573
artikel
1805 Enhanced Phosphorylation of Nbs1, a Member of the DNA Repair/Checkpoint Activation Complex Rad50/Mre11/Nbs1, Prolongs Cell Cycle S Phase and Contributes to Drug Resistance in BCR/ABL-Positive Leukemias. Rink, Lori

106 11 p. 2867
artikel
1806 Enhanced Potency of Glycoengineered Anti-CD52 Monoclonal Antibodies (MAbs). Dyer, Martin J.S.

106 11 p. 2958
artikel
1807 Enhanced Safety and Tolerability of Dose Intensive Pentostatin and Rituximab in Patients with CLL or Low-Grade B-Cell NHL. Mena, Raul M.

106 11 p. 937
artikel
1808 Enhanced Survival of MDS Progenitor Cells under Hypoxic Conditions. Thompson, James E.

106 11 p. 3427
artikel
1809 Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts. Seifert, Georg

106 11 p. 3919
artikel
1810 Enhancement of Tissue Factor Dependent Procoagulant Activity and Factor Xa Generation by Alpha2-Macroglobulin. Bhattacharjee, Gourab

106 11 p. 1941
artikel
1811 Enhancing Neutrophil Differentiation - A Novel Role for the Death-Associated Protein Kinase 2 (DAPK2). Rizzi, Mattia

106 11 p. 1348
artikel
1812 Enhancing the Therapeutic Potential of an Anti-Leukemic Peptide. Palermo, Christine M.

106 11 p. 245
artikel
1813 Enzastaurin (LY317615), an Oral Protein Kinase C β Inhibitor, Induces Apoptosis in Multiple Myeloma Cell Lines. Rizvi, Mujahid A.

106 11 p. 1577
artikel
1814 Enzymatically-Active ADAMTS13 Variants Are Not Inhibited by Anti-ADAMTS13 Autoantibodies - A Potential Novel Therapeutic Strategy. Zhou, Wenhua

106 11 p. 57
artikel
1815 Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children's Oncology Group Study. Jacobsohn, David A.

106 11 p. 5375
artikel
1816 Epidemiology and Features of Multiple Myeloma in a Cohort of 110 Patients from a Central Area of Israel. Duek, Adrian

106 11 p. 5169
artikel
1817 Epidemiology of Adult Acute Lymphoblastic Leukemia in Manitoba, Canada: Does This Approximate Clinical Trial Data?. Dao, Vi

106 11 p. 4554
artikel
1818 Epidemiology of Fungal Infections in Hematological Malignancies in Italy: SEIFEM-2004 Study (Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne). Pagano, Livio

106 11 p. 4556
artikel
1819 Epidemiology of Immune Thrombocytopenic Purpura in the United Kingdom, Germany, and the Netherlands. Satia, Jessie A.

106 11 p. 5554
artikel
1820 Epidemiology of Multiple Myeloma in Spain: An Analytic Review. Alegre, A.

106 11 p. 5089
artikel
1821 Epigenetic Changes in the γ-Globin Gene Promoter in Hematopoietic Progenitor Cells at Different Stages of Differentiation. Singh, Mahipal

106 11 p. 1742
artikel
1822 Epitope Mapping of Inhibitors in Acquired Hemophilia by Phage Display. Königs, Christoph

106 11 p. 3202
artikel
1823 Epoetin and Darbepoetin To Treat Cancer Patients: Updated Meta-Analysis Results. Bohlius, Julia

106 11 p. 751
artikel
1824 Epstein-Barr Virus in Patients with Chronic Lymphocytic Leukemia. Tsimberidou, Apostolia-Maria

106 11 p. 2113
artikel
1825 Equivalence of Liquid and Freeze-Dried Formulations of WinRho® SDF. Sinclair, Christopher J.

106 11 p. 3988
artikel
1826 ERBB Expression in Philadelphia Chromosome-Positive ALL as a Potential Therapeutic Target. Hughes, Dennis P.M.

106 11 p. 860
artikel
1827 Erythrocyte Adenylate Kinase Deficiency: First In-Depth Biochemical Characterization of the Y164C Mutant Enzyme Causing Hemolytic Anemia. Abrusci, Patrizia

106 11 p. 3602
artikel
1828 Erythroid Kruppel-Like Factor Regulates E2F4 and the G1 Cdk Inhibitor, p18. Perkins, Andrew C.

106 11 p. 1357
artikel
1829 Erythropoietic Therapy Does Not Stimulate Tumor Growth in Erythropoietin Receptor (EPOR)-Positive MDA-MB-231 and MCF-7 Breast Carcinoma Models. LaMontagne, Kenneth R.

106 11 p. 4260
artikel
1830 Erythropoietin and Erythropoietin Receptor Expression in Early Stage Non-Small Cell Lung Cancer: Prognostic Significance. Amin, Khalid

106 11 p. 4258
artikel
1831 Erythropoietin Protects Cardiomyocytes Not Only during Hypoxic Injury but Also Against Doxorubicin-Induced Apoptosis: A Novel Effect Mediated by Phosphatidylinositol 3-Kinase Pathway. Fu, Ping

106 11 p. 3142
artikel
1832 Erythropoietin Response to Anemia Is Impaired in Patients with Hematologic Malignancies. Shen, Ti

106 11 p. 3744
artikel
1833 Erythropoietin Signaling Inhibits the Short-Term Marrow Reconstitution. Chang, Ko-Tung

106 11 p. 3028
artikel
1834 ESHAP with Rituximab Is Highly Efficacious with Durable Responses in Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma. Threja, Rekha R.

106 11 p. 4787
artikel
1835 Essential Role and Regulatory Mechanism of the Erythropoietin Gene in the Liver. Suzuki, Norio

106 11 p. 3138
artikel
1836 Essential Role for Activated Leukocyte Cell Adhesion Molecule in Transendothelial Migration. Ofori-Acquah, Solomon F.

106 11 p. 3691
artikel
1837 Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation. Steidl, Ulrich

106 11 p. 463
artikel
1838 Essential Role of the INK4/CDK4,6/Rb/E2F Signaling Pathway in AML with the Flt3 Internal Tandem Duplication. Wang, Lisheng

106 11 p. 2752
artikel
1839 Essential Thrombocythemia: Analysis of Risk Factors for Thrombotic Events in a Series of 306 Patients. Radaelli, Franca

106 11 p. 4937
artikel
1840 Establishment and Characterization of a New Human Myeloma Cell Line WuS1. Sun, Wanling

106 11 p. 5114
artikel
1841 Establishment and Characterization of a New Human Ph+ Erythroleukemic Cell Line, VES. Golemovic, Mirna

106 11 p. 4558
artikel
1842 Establishment and Indentification of Genetic Alterations in Chemotherapy-Resistant T-ALL Cell Lines. Estes, David A.

106 11 p. 4423
artikel
1843 Establishment of a Waldenstrom's Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice. Santos, Daniel Ditzel

106 11 p. 979
artikel
1844 Estimated Annual Number of Incident and Recurrent, Non-Fatal and Fatal Venous Thromboembolism (VTE) Events in the US. Heit, John A.

106 11 p. 910
artikel
1845 Estimated Annual Number of US Acute-Care Hospital Inpatients Meeting ACCP Criteria for Venous Thromboembolism (VTE) Prophylaxis. Anderson Jr, Frederick A.

106 11 p. 903
artikel
1846 Estimating Immunoregulatory Gene Networks in Human Herpesvirus Type 6 (HHV-6)-Infected T Cells. Takaku, Tomoiku

106 11 p. 2381
artikel
1847 Estimating the Replication Rate of Hematopoietic Stem Cells in Non-Human Primates: A Test of Hayflick's Hypothesis. Shepherd, Bryan E.

106 11 p. 1710
artikel
1848 Estimating the Total Cost of Infused Iron Chelation Therapy. Desrosiers, Marie-Pierre

106 11 p. 5576
artikel
1849 Estrogen and Progesteron Receptor Status in Pediatric and Adolescent Patients with Hodgkin's Lymphoma. Claviez, Alexander

106 11 p. 4648
artikel
1850 Estrogen-Based Hormone Therapy and Thrombosis Risk in Women with Essential Thrombocythemia. Gangat, Naseema

106 11 p. 2594
artikel
1851 Ethnic and Serologic Differences Predict Clinical Behavior and Response in Immune Thrombocytopenia (ITP). Rajan, Sandeep K.

106 11 p. 3985
artikel
1852 Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt's Lymphoma Cells. Kobayashi, Miki

106 11 p. 4825
artikel
1853 Etoposide-Initiated MLL Rearrangements Detected at High Frequency in Human Primitive Hematopoietic Stem Cells with In Vitro and In Vivo Long-Term Repopulating Potential. Libura, Jolanta

106 11 p. 98
artikel
1854 ETV6/TEL1 Is Required for HSC Emergence during Embryonic Development. Pinheiro, Philip

106 11 p. 3607
artikel
1855 European Collaborative Paediatric Database on Cerebral Sinus Venous Thrombosis (CVT): Risk of Recurrent Venous Thrombosis (Update 2005). Kenet, Gili

106 11 p. 1629
artikel
1856 European Multi-Centre Study on the Use of Anti-Thymocyte Globulin in the Treatment of Myelodysplastic Syndromes. Lim, ZiYi

106 11 p. 2518
artikel
1857 Euthanasia: History, Definitions and Clinical Guidelines from Classical Jewish Sources. Gesundheit, Benjamin

106 11 p. 5572
artikel
1858 Evaluating the Outcomes of Quality Improvement Initiatives of a Multi-Disciplinary Heparin-Induced Thrombocytopenia (HIT) Task Force. Davis, Elaine A.

106 11 p. 2252
artikel
1859 Evaluation of Anemia in Adults: Going after the Common Causes. McPhedran, Peter

106 11 p. 3769
artikel
1860 Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US). McArthur, Heather L.

106 11 p. 2812
artikel
1861 Evaluation of a New Program for PBSC Collection with Fresenius COM.TEC Blood Cell Separator. Del Fante, Claudia

106 11 p. 5265
artikel
1862 Evaluation of a Non-Invasive Hematocrit Determination Device. Berrebi, Alain

106 11 p. 4176
artikel
1863 Evaluation of CD52 Expression in Hematopoietic Neoplasms by Standard Immunohistochemistry: Implications for the Expanded Use of Alemtuzumab (CAMPATH-1H) in the Treatment of Hematological Malignancies. Rodig, Scott J.

106 11 p. 3346
artikel
1864 Evaluation of Costs of Healthcare in HIV Patients with Anemia. Dickson, Michael

106 11 p. 5557
artikel
1865 Evaluation of Immunophenotypes and Activities of Cell Membrane Microparticles in Apheresis Platelets: Impact of Seven Day Storage. Gelderman-Fuhrmann, Monique P.

106 11 p. 1893
artikel
1866 Evaluation of Molecular Response by Real-Time RT-PCR in Acute Promyelocytic Leukemia (APL): A Direct Comparison with Regular RT-PCR. Hu, Jiong

106 11 p. 4486
artikel
1867 Evaluation of Ph+/CD34+ Residual Cells in Chronic Myeloid Leukemia Patients after Long Lasting Treatment with Imatinib Mesylate. Bocchia, Monica

106 11 p. 1999
artikel
1868 Evaluation of Platelets Obtained from Premature Neonates To Determine Whether Platelet Dysfunction Mediates the Development of Intraventricular Hemorrhage. McCarthy, Sean T.

106 11 p. 4013
artikel
1869 Evaluation of Platelet Thrombus Formation under Flow. Stoldt, Volker R.

106 11 p. 3964
artikel
1870 Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim. Bonfichi, Maurizio

106 11 p. 4245
artikel
1871 Evaluation of Qualitative Platelet Disorders in Patients with Hemophilia. Kraut, Eric H.

106 11 p. 3987
artikel
1872 Evaluation of Response to Anti-CD20 (Rituximab) Trial in Relapsed Follicular Lymphoma after Six Years in Follow-Up. Rubio-Martinez, Araceli

106 11 p. 4784
artikel
1873 Evaluation of the CD8+ Tumor Associated vs. Non-Tumor Associated Immune Repertoire in Cancer Patients Following Induction of Lymphopenia and Following CD3/4-1BB Based Expansion. Snyder, Kristen

106 11 p. 2390
artikel
1874 Evaluation of the In Vitro Activity of the Multikinase Inhibitor BAY 43-9006 (Sorafenib) in Primary Cells from Patients with Myelofibrosis with Myeloid Metaplasia (MMM). Smith, Joseph W.

106 11 p. 4943
artikel
1875 Evaluation of the Oncohaematologic Pathology of Two Oncologics Centers of Buenos Aires, Argentina in the Period between 1995–2005; a Total of 1884 Cases. Dragosky, Marta O.

106 11 p. 4683
artikel
1876 Evaluation of the Phenotype and GVHD-Inducing Potential of Splenic T Cells Isolated from G-CSF, AMD3100, or G-CSF and AMD3100 Pretreated Allogeneic Donors. Rettig, Michael

106 11 p. 5224
artikel
1877 Evaluation of the Prognostic Implications of Pro- and Anti-Angiogenic Cytokines in 311 Patients with Untreated Chronic Lymphocytic Leukemia. Shanafelt, Tait D.

106 11 p. 712
artikel
1878 Evaluation of the Specificity and Cytotoxicity of Three Proteasome Inhibitors. Crawford, Lisa J.A.

106 11 p. 3366
artikel
1879 Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis. Krause, Manuela

106 11 p. 4072
artikel
1880 Evaluation of Tonsillectomy and Lymphoma Workup -Who Should Get a Lymphoma Workup? Is It Cost Effective?. Yeung, Cecilia C.

106 11 p. 3128
artikel
1881 Evaluation of Trends in Imatinib Dosing over Time: A Retrospective Cohort Study. Hamdan, Muhammad

106 11 p. 3117
artikel
1882 Evaluation of ZAP-70 Expression Using Real-Time Quantitative RT-PCR (RQ-PCR) in Chronic Lymphocytic Leukemia (CLL), a Reference Method for Flow Cytometry (FCM) Harmonization?. Letestu, Remi

106 11 p. 1195
artikel
1883 Event Rate for Patients with Atrial Fibrillation with and without Low Molecular Weight Heparin Bridging. Billett, Henny Heisler

106 11 p. 916
artikel
1884 Evidence for Alternative Lengthening of Telomeres in Chronic Lymphocytic Leukemia Patients. Damle, Rajendra N.

106 11 p. 1179
artikel
1885 Evidence for an Inhibitor-Blocking Antibody in an "Acquired Hemophiliac". Litwiller, Robert

106 11 p. 3209
artikel
1886 Evidence for a Novel Blood Lineage Commitment Pathway from Lympho-Myeloid Hematopoietic Stem Cells. Jacobsen, Sten Eirik W.

106 11 p. 802
artikel
1887 Evidence for a Novel Splice Variant of the Gene for Platelet Activating Factor Acetylhydrolase 1B2 (PAFAH1B2), an Important Signal Terminator in the Platelet Activating Factor (PAF) Pathway. Olson, Nels

106 11 p. 2630
artikel
1888 Evidence for Control of von Willebrand Factor Multimer Size by Intramolecular Thiol-Disulfide Exchange. Ganderton, Tim

106 11 p. 412
artikel
1889 Evidence for Differential Regulation of Transferrin Receptor 1 in Normal vs. Malignant B Cells. Chiotoglou, Ioanna

106 11 p. 3722
artikel
1890 Evidence for Disease Specific Immunophenotypic Abnormalities in Blood from Patients with Mantle Cell Lymphoma. Narvaez, Amy B.

106 11 p. 4684
artikel
1891 Evidence for Involvement of Clonally Expanded CD8+ T Cells in Anti-Cancer Immune Responses in CLL Patients Following Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT). Kollgaard, Tania

106 11 p. 1260
artikel
1892 Evidence for Pulmonary Vascular Disease Despite Absence of Overt Pulmonary Arterial Hypertension (PAH) in Myeloproliferative Disorders (MPD) (PV and ET). Kiladjian, Jean-Jacques

106 11 p. 4939
artikel
1893 Evidence for Restricted Glycolytic Metabolism in Primary CD133+ Cells. Alt, Ruediger

106 11 p. 1726
artikel
1894 Evidence for Ribosomal Insufficiency Affecting Non-Erythroid Cells in RPS19 and Non-RPS19 Mutated DBA. Ball, Sarah

106 11 p. 3547
artikel
1895 Evidence for T-Cell Oligoclonal Expansion in Aplastic Anemia Associated with Telomerase Complex Mutations: Pathophysiological and Clinical Implications. Calado, Rodrigo T.

106 11 p. 1052
artikel
1896 Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo. Neuenschwander, Pierre F.

106 11 p. 1020
artikel
1897 Evidence That Fibrinogen Inhibits Leukocyte Adhesion to Fibrin Clot and Immobilized Fibrinogen by Binding to the Substrate but Not to Integrins. Lishko, Valeryi K.

106 11 p. 2631
artikel
1898 Evidence That Functional Neural Tissue-Committed Stem Cells (NTCSC) Reside in the Human Bone Marrow and Are Mobilized into Peripheral Blood in a Patients after Stroke. Kucia, Magda

106 11 p. 392
artikel
1899 Evidence That the COOH-Terminal Region of Factor Va Heavy Chain Is Involved in the Regulation of Prothrombinase Activity. Hirbawi, Jamila

106 11 p. 1025
artikel
1900 Evolutionarily Conserved Coupling of Transcription and Alternative Splicing in the Protein 4.1R and 4.1B Genes Regulates N-Terminal Protein Structure. Tan, Jeff

106 11 p. 1664
artikel
1901 Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine. Bernasconi, Paolo

106 11 p. 4973
artikel
1902 Examination of ALAS2, ABC7, Rag1, and IL6 Genes as Candidate Modifiers of Iron Overload in HFE C282Y Homozygotes with Severe Iron Overload. Lee, Pauline L.

106 11 p. 3724
artikel
1903 Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population. Ballen, Karen K.

106 11 p. 2048
artikel
1904 Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group. Tsukimoto, Ichiro

106 11 p. 889
artikel
1905 Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL). Vassilakopoulos, Theodoros P.

106 11 p. 935
artikel
1906 Excellent Results in Children and Adolescents with Isolated Mature B-Acute Lymphoblastic Leukemia (B-ALL) (Burkitt): Report from the French-American-British (FAB) International LMB Study FAB/LMB96. Goldman, Stan

106 11 p. 234
artikel
1907 Excellent Stem Cell Mobilization Using Escalated BEACOPP in High-Risk Patients with Hodgkin's Disease. Kandler, Gabriele

106 11 p. 4717
artikel
1908 Exchange of International Staging System for Durie&Salmon Staging System in Therapeutic Strategy for Multiple Myeloma. Kurahashi, Shingo

106 11 p. 5167
artikel
1909 Exchange Transfusion in Newborn Infants Activates Coagulation and Alters the Coagulation Profile. Hyytiäinen, Satu

106 11 p. 953
artikel
1910 Exhaled Nitric Oxide (eNO) and Pulmonary Function after Total Body Irradiation (TBI) Based Non Myeloablative Conditioning Regimens and Allogeneic Hematopoietic Cell Transplant. Giaccone, Luisa

106 11 p. 5311
artikel
1911 Existing Warfarin Therapy in Long-Term Care Facilities Maybe Inadequate. Motlagh, Bahareh

106 11 p. 4160
artikel
1912 Exisulind Selectively Induces Apoptosis Via C-Jun Kinase Activation in MDS and sAML/MDS. Czibere, Akos

106 11 p. 4902
artikel
1913 Exogenous C/EBPα Favors the Monocytic Commitment and Maturation of Normal Murine Myeloid Progenitors. Wang, Dehua

106 11 p. 2711
artikel
1914 Exon-12 Nucleophosmin (NPM) Mutation and Aberrant Cytoplasmic Expression of NPM Protein in Leukemia Cell Line OCI-AML3. Quentmeier, Hilmar

106 11 p. 2376
artikel
1915 Exosite-Specific Inhibition of Thrombin Using Photo-Crosslinked Fluorescent Reporter Peptides. Yegneswaran, Subramanian

106 11 p. 1954
artikel
1916 Expanded Human NKT Type II Cells: Effective Against Colon Cancer Cells, Safe across Major MHC Barriers and Successfully Expandable after Non-Myeloablative HCT for Solid Tumors. Sangiolo, Dario

106 11 p. 5239
artikel
1917 Expansion of Genetically Modified Primary Human Hematopoietic Cells Using a Cell Growth Switch. Wang, Linlin

106 11 p. 3044
artikel
1918 Expansion of Normal and Leukemic Human Hematopoietic Stem/Progenitor Cells Requires Rac-Mediated Interaction with Stromal Cells. Schuringa, Jan Jacob

106 11 p. 1398
artikel
1919 Experimental Metastasis, Tumor Cell-Induced Coagulopathy and Primary Tumor Growth in Mice with Hemophilia A. Langer, Florian

106 11 p. 725
artikel
1920 Experimental Study on the Relationship between Heparin Sulfate Proteoglycans of Endothelial Cells and Cell Adhesion. Qiao, Zhenhua

106 11 p. 3855
artikel
1921 Exploring Patient Satisfaction with Long-Term Warfarin for the Treatment of Atrial Fibrillation. Murray, Miranda

106 11 p. 2245
artikel
1922 Exploring the Molecular Mechanisms for Enhancing MSC Homing and Lodgement within Sites of Liver Damage/Fibrosis. Herrbrich, Phillip E.

106 11 p. 1690
artikel
1923 Exposure of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII. Bukys, Michael A.

106 11 p. 1951
artikel
1924 Expression and Activation of the Farnsesoid X Receptor in Human Dendritic Cells. Ziros, Panos

106 11 p. 2220
artikel
1925 Expression and Functional Analysis of Disintegrin from Agkistrodon Actus Venom. Bai, Xia

106 11 p. 3963
artikel
1926 Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone. Chauhan, Dharminder

106 11 p. 4447
artikel
1927 Expression Levels of CD38 in Tumor Cells and T-Cells Are of Prognostic Value in B-CLL. Tinhofer, Inge

106 11 p. 1189
artikel
1928 Expression Level, Tissue Distribution Pattern and Prognostic Impact of Vascular Endothelial Growth Factor (VEGF) and Its Receptors Flt-1 and KDR in Different Subtypes of Non-Hodgkin Lymphoma (NHL). Jørgensen, Judit M.

106 11 p. 2824
artikel
1929 Expression of Activation Marker, CMRF-44, on Blood CD11c+ Dendritic Cells Is Closely Associated with the Severity of Acute GVHD after Allogeneic Haematopoietic Stem Cell Transplant. Lau, Jenny

106 11 p. 600
artikel
1930 Expression of a KCC1 Splice Variant Is Suppressed by NF-ΚB in Erythroid Cells. Anderson, Kathleen P.

106 11 p. 1669
artikel
1931 Expression of Angiogenin in Normal B Lymphocytes and B-CLL Cells. Paul, Santanu

106 11 p. 1188
artikel
1932 Expression of ATRA Inducible RARα2 Isoform Is Deregulated in AML. Glasow, Annegret

106 11 p. 1204
artikel
1933 Expression of Cadherins in Bone Marrow Stromal Cells Affects Capacity Supporting Expansion of CD34+ Cord Blood Cells. Liu, Jin-Hwang

106 11 p. 4311
artikel
1934 Expression of Cancer/Testis Antigens CT10 and SSX in Multiple Myeloma: Promising Targets for Antigen-Specific Immunotherapy. Atanackovic, Djordje

106 11 p. 3468
artikel
1935 Expression of CD49c and CD49d Chains of β1 Integrins Identifies B-CLL Subsets with Different Prognosis and Distinct Immunophenotypic Profiles. Gattei, Valter

106 11 p. 1196
artikel
1936 Expression of CD25+ Cell Subsets after Induction Chemotherapy in Adult Patients with Acute Myeloid Leukemia. Min, Woo-Sung

106 11 p. 4597
artikel
1937 Expression of CD18 in Leukocytes Following Retroviral Mediated Gene Transfer Reverses the Clinical Phenotype in Canine Leukocyte Adhesion Deficiency. Hai, Mehreen

106 11 p. 459
artikel
1938 Expression of C/EBPε Restores G-CSF-Induced Granulocytic Differentiation of Myeloid Cells Expressing the Carboxy Truncated G-CSF Receptor Associated with AML/SCN. Dong, Fan

106 11 p. 3154
artikel
1939 Expression of Cellular Prion Protein (PrPc) on Human Red Blood Cells. Panigaj, Martin

106 11 p. 1898
artikel
1940 Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells. Murohashi, Ikuo

106 11 p. 4391
artikel
1941 Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies. Abdalla, Amir

106 11 p. 4278
artikel
1942 Expression of Fetal Hemoglobin among Adult Human Erythroblasts Is Associated with an Altered Expression Pattern for the Transcription Factor c-Myb. Rudrabhatla, Parvathi

106 11 p. 3635
artikel
1943 Expression of Hes-1 (Notch-1 Effector) during “In Vitro” Normal Erythroid Differentiation. Cappellini, Maria D.

106 11 p. 4287
artikel
1944 Expression of Human Amyloidogenic Immunoglobulin Light Chains in Mice Leads to Organ Toxicity. Ward, Jennifer E.

106 11 p. 3412
artikel
1945 Expression of Inhibitor-of-Apoptosis Protein (IAP) Livin in Pediatric Acute Lymphoblastic Leukemia (ALL) Cells. Dasgupta, Anindya

106 11 p. 4526
artikel
1946 Expression of Interleukin-7 Receptor and Activation Markers on Central Memory CD8 Cells in HIV-Infected Individuals Treated with Antiretrovirals. Routy, Jean Pierre

106 11 p. 1438
artikel
1947 Expression of Leukemia-Associated Antigens (LAA) in Patients with Acute Myelogenous Leukemia (AML). Schoettker, Bjoern

106 11 p. 4497
artikel
1948 Expression of Lymphocyte Activation Gene 3 (LAG-3/CD223) by Chronic Lymphocytic Leukemia B Cells. Chuang, Han-Yu

106 11 p. 2952
artikel
1949 Expression of Protein Z (PZ) and Protein Z-Dependent Protease Inhibitor (ZPI) In Situ in Human Malignant Tissues. Sierko, Ewa

106 11 p. 1028
artikel
1950 Expression of Runx1 Isoforms in Sub-Populations of Human Blood and Bone Marrow Cells. Yankelevich, Maxim

106 11 p. 4244
artikel
1951 Expression of Specialized Error-Prone DNA Polymerases in Chronic Lymphocytic Leukemia (CLL). Crespo, Marta

106 11 p. 2941
artikel
1952 Expression of T Cell Co-Stimulator (ICOS) and Its Ligand and Disease Progression in B-Cell Chronic Lymphocytic Leukemia. Fukuda, Tetsuya

106 11 p. 2943
artikel
1953 Expression of the BAFF-R (BR3) Is Positive in a Minority of Diffuse Large B Cell Lymphomas and Does Not Correlate with the Germinal Center or Non Germinal Center Origin of Lymphomatous Cells. Proust, Alexis

106 11 p. 4711
artikel
1954 Expression of the Human Germinal Center Associated Lymphoma (HGAL) Protein Identifies a Subset of Classical Hodgkin Lymphoma of Germinal Center Derivation and Improved Outcome. Natkunam, Yasodha

106 11 p. 23
artikel
1955 Expression of the Iron Regulatory Peptide Hepcidin Is Reduced in Patients with Chronic Liver Disease. Anderson, Greg

106 11 p. 3591
artikel
1956 Expression of the Smad3 Transgene Restores Radiosensitivity and Migratory Capacity to a Smad3−/− Clonal Bone Marrow Stromal Cell Line. Epperly, Michael W.

106 11 p. 4307
artikel
1957 Expression of the Wilms' Tumor 1 (WT1) Gene Renders Acute Promyelocytic Leukemia Cells Resistant to All-Trans-Retinoic-Acid-Induced Differentiation. Menke, Aschwin L.

106 11 p. 4385
artikel
1958 Expression of Transcription Factors NFAT1, c-Jun, c-Fos, and Bach2 in Umbilical Cord Blood and Adult Blood T-Cells. Huang, Ying

106 11 p. 3935
artikel
1959 Expression of Tropomodulin1 (Tmod1) in the Heart Rescues Embryonic Lethality of Tmod1 Null Mice and Results in a Mild Hemolytic Anemia Due to Absence of Tmod1 in Red Blood Cells. Fowler, Velia M.

106 11 p. 807
artikel
1960 Expression of Vascular Endothelial-Cadherin on Leukemic Cells Mediates Their Interaction with Vascular Endothelium. Ellis, Leslie R.

106 11 p. 2761
artikel
1961 Expression of Vascular Endothelial Growth Factor (VEGF) Associated with Its Receptor (VEGFR) in Relation to Tissue Factor (TF) in Human Breast Cancer Tissue. Wojtukiewicz, Marek

106 11 p. 4024
artikel
1962 Expression of VEGF-C and Its Receptor VEGFR-3 in Diffuse Large B-Cell Lymphomas. Pazgal, Idit

106 11 p. 4666
artikel
1963 Expression of X-Linked Inhibitor of Apoptosis Protein in Reactive Lymphoid Tissues, Non-Hodgkin's Lymphomas, and Hodgkin's Disease. Strauchen, James A.

106 11 p. 4655
artikel
1964 Expression Profiles of VDR-Induced Differentiation of atRA Refractory AML Cell Lines. Baudet, Aurelie

106 11 p. 3291
artikel
1965 Extended Follow-Up and Analysis with Central Radiological Review of Patients Receiving FavId® (Id/KLH) Vaccine Following Rituximab. Koc, Omer

106 11 p. 772
artikel
1966 Extended Follow-Up of a Chemo-Immunotherapy Regimen FCR (Fludarabine, F; Cyclophosphamide, C; and Rituximab, R) as Initial Therapy for Chronic Lymphocytic Leukemia (CLL). Keating, Michael J.

106 11 p. 2118
artikel
1967 Extended Study for Topotecan, Idarubicin, and Intermediate-Dose Cytarabine Combination Chemotherapy in Patients with Refractory or Relapsed Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome. Kim, Yuri

106 11 p. 4609
artikel
1968 Extended Thromboprophylaxis with Fondaparinux after Major Orthopedic Surgery of the Lower Limbs: The EXPERT Study. Singelyn, Francois

106 11 p. 282
artikel
1969 Extra-Cellular DNA in Cord Blood (CB) Plasma: Use for Sample Identification [short Tandem Repeat (STR) Analysis] and for Infectious Disease Screening in CB Banks. Albano, Maria S.

106 11 p. 1901
artikel
1970 Extracellular Endosulfatases (Sulfs) Inhibit Myeloma Tumor Growth In Vivo. Dai, Yuemeng

106 11 p. 3386
artikel
1971 Extracorporeal Photopheresis Induces the Generation of Regulatory T Cells. Strobl, Frank

106 11 p. 3104
artikel
1972 Extracorporeal Photopheresis, Pentostatin, and TBI for Reduced-Intensity Preparation: Adaptation of the Tufts Experience at a Single Transplant Center. Liesveld, Jane L.

106 11 p. 5417
artikel
1973 Ex-Vivo Assessments in the Evaluation of Dose Response to Recombinant Factor VIIa When Administered for Bleeding Following Punch Biopsies in Healthy Volunteers. Gabriel, Don A.

106 11 p. 4055
artikel
1974 Ex Vivo Expanded Erythroid Progenitor Cells Augment Therapeutic Angiogenesis by Extensive Cytokine Production. Muta, Koichiro

106 11 p. 3966
artikel
1975 Ex-Vivo Expansion and Prophylactic Infusion of CMV pp65 Specific CTL Following Haemopoietic Stem Cell Transplantation (HSCT). Gottlieb, David J.

106 11 p. 3244
artikel
1976 Ex Vivo Expansion of Canine CD4+CD25+ Regulatory T Cells (Treg) with Artificial Antigen Presenting Cells (aAPC). Lesnikova, Marina

106 11 p. 3102
artikel
1977 Ex Vivo Expansion of Human SCID-Repopulating Cells Using Recombinant TAT-HOXB4 Protein. Krosl, Gorazd

106 11 p. 3159
artikel
1978 Ex Vivo Expansion of Umbilical Cord Blood T Cells for Adoptive Immunotherapy. Mazur, Melissa A.

106 11 p. 35
artikel
1979 Ex Vivo Fludarabine Selectively Depletes Human Naive T-Cell Subsets: A Step Toward Modifying Donor Lymphocyte Infusion. Smith, Melody M.

106 11 p. 1071
artikel
1980 Ex Vivo Large Scale Generation of Human Platelets from Cord Blood CD34+ Cells. Matsunaga, Takuya

106 11 p. 1892
artikel
1981 Factor IX Substrate Binding Exosite on the Light Chain of Factor Xia. Sinha, Dipali

106 11 p. 1959
artikel
1982 Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin's Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue. Balzarotti, Monica

106 11 p. 2091
artikel
1983 Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT). Villanueva, Mary Lee H.

106 11 p. 1754
artikel
1984 Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). Decousus, Hervé

106 11 p. 264
artikel
1985 Factor V G1691A Mutation and Factor II G20210A Variant in Children with Venous Thrombosis or Stroke. An International Database Update. Nowak-Gottl, Ulrike

106 11 p. 4117
artikel
1986 Factor VII Deficiency Presenting with Recurrent Intracranial Bleeding and rFVIIa Prophylaxis. Salcioglu, Zafer

106 11 p. 4086
artikel
1987 Factor VII Deficiency Remains Post-Puberty Due to Point Mutation in the HNF4 Binding Site in the Coagulant Factor VII Gene. Zheng, XingWu

106 11 p. 1947
artikel
1988 Factor VIIIa Decay Due to A2 Subunit Dissociation Is Regulated by the A1 Domain. Parker, Ernest T.

106 11 p. 1009
artikel
1989 Factor VIII A2 Domain Residues 497–510 and 584–593 Comprise the R8B12 Epitope. Ansong, Charles

106 11 p. 4028
artikel
1990 Factor VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates. von Auer, Charis

106 11 p. 3198
artikel
1991 Factor VIII Inhibitors in Haemophilia A Patients Who Are Considered as Previously Treated Patients. von Auer, Charis

106 11 p. 4105
artikel
1992 Factor VIII Levels Measured at the Time of Diagnosis of Acute Idiopathic Venous Thromboembolism Are Higher Then When Measured Six-Months Post Diagnosis. Kovacs, Michael J.

106 11 p. 4136
artikel
1993 Factor V Level Affects the Host Susceptibility to Group A Streptococcal Infection. Sun, Hongmin

106 11 p. 25
artikel
1994 Factor XIII Val34Leu Polymorphism and the Risk of Myocardial Infarction: A Meta-Analysis. Shafey, Mona

106 11 p. 1637
artikel
1995 Falsely Low Serum Free Light Chain Concentration in Patients with Monoclonal Light Chain Diseases. Mollee, Peter

106 11 p. 5077
artikel
1996 Familial Acute Myeloblastic Leukemia with a Dominant Negative Mutation in the CEBPA Gene. Nanri, Tomoko

106 11 p. 4564
artikel
1997 Familial Bernard-Soulier Syndrome Due to a Novel Ins/Del Mutation in Glycoprotein IX. Cutler, Jacky

106 11 p. 2178
artikel
1998 Familial Erythrocytosis Associated with a Mutation in the HIF Prolyl Hydroxylase, PHD2. Percy, Melanie J.

106 11 p. 127
artikel
1999 Familial Thrombotic Thrombocytopenic Purpura in Three Siblings. Niewiadomska, Edyta

106 11 p. 4042
artikel
2000 Fanconi Anemia D2 Protein Contributes to BCR/ABL-Mediated Transformation of Hematopoietic Cells. Koptyra, Mateusz

106 11 p. 2878
artikel
                             5591 gevonden resultaten
 
<< vorige    volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland